UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________ 
FORM 10-Q
________________________
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2014
Or
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from             to             
Commission File Number 001-32498
 ________________________ 
Xerium Technologies, Inc.
(Exact name of registrant as specified in its charter)
 ________________________ 
 
DELAWARE
42-1558674
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
 
14101 Capital Boulevard
Youngsville, North Carolina
27596
(Address of principal executive offices)
(Zip Code)
(919) 526-1400
(Registrant’s telephone number, including area code)


(Former name, former address and former fiscal year, if changed since last report)
 ________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
  £
 
 
 
Accelerated filer
 
  x
Non-accelerated filer
 
  £
 
(Do not check if a smaller reporting company)
 
Smaller reporting company
 
  £
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).    Yes  ¨    No  ý
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.    Yes  ý    No  ¨
The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of November 3, 2014 was 15,555,748.
 



TABLE OF CONTENTS
 

2



PART I. FINANCIAL INFORMATION
ITEM 1.
UNAUDITED FINANCIAL STATEMENTS

Xerium Technologies, Inc.
Consolidated Balance Sheets
(Dollars in thousands and Unaudited)
 
September 30, 2014
 
December 31,
2013
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
19,813

 
$
25,716

Accounts receivable, net
88,042

 
87,952

Inventories, net
86,442

 
83,930

Prepaid expenses
7,766

 
8,179

Other current assets
14,512

 
15,695

Total current assets
216,575

 
221,472

Property and equipment, net
311,927

 
309,664

Goodwill
63,003

 
68,975

Intangible assets
12,672

 
14,470

Other assets
7,071

 
9,483

Total assets
$
611,248

 
$
624,064

LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
 
 
Current liabilities:
 
 
 
Notes payable
$
7,611

 
$
8,267

Accounts payable
35,847

 
42,220

Accrued expenses
68,614

 
61,368

Current maturities of long-term debt
2,362

 
2,166

Total current liabilities
114,434

 
114,021

Long-term debt, net of current maturities
461,284

 
432,706

Liabilities under capital leases
4,100

 

Deferred taxes
13,523

 
16,350

Pension, other post-retirement and post-employment obligations
61,575

 
66,866

Other long-term liabilities
7,485

 
5,570

Commitments and contingencies


 


Stockholders’ deficit
 
 
 
Preferred stock, $0.001 par value, 1,000,000 shares authorized; no shares outstanding as of September 30, 2014 and December 31, 2013

 

Common stock, $0.001 par value, 20,000,000 shares authorized; 15,555,748 and 15,383,903 shares outstanding as of September 30, 2014 and December 31, 2013, respectively
16

 
15

Stock warrants

 
13,532

Paid-in capital
428,051

 
414,742

Accumulated deficit
(428,228
)
 
(409,686
)
Accumulated other comprehensive loss
(50,992
)
 
(30,052
)
Total stockholders’ deficit
(51,153
)
 
(11,449
)
Total liabilities and stockholders’ deficit
$
611,248

 
$
624,064



3


Xerium Technologies, Inc.
Consolidated Statements of Operations
(Dollars in thousands, except per share data and unaudited)
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net Sales
$
138,858

 
$
135,042

 
$
411,965

 
$
413,171

Costs and expenses:
 
 
 
 
 
 
 
Cost of products sold
83,364

 
81,656

 
248,954

 
252,628

Selling
18,195

 
17,779

 
55,362

 
55,049

General and administrative
14,133

 
15,278

 
43,337

 
45,418

Research and development
1,909

 
1,845

 
5,899

 
5,934

Restructuring
3,466

 
3,034

 
15,712

 
8,454

 
121,067

 
119,592

 
369,264

 
367,483

Income from operations
17,791

 
15,450

 
42,701

 
45,688

Interest expense, net
(9,412
)
 
(9,378
)
 
(26,985
)
 
(31,697
)
Loss on extinguishment of debt

 

 

 
(3,123
)
Foreign exchange gain (loss)
367

 
(905
)
 
(818
)
 
(1,102
)
Income before provision for income taxes
8,746

 
5,167

 
14,898

 
9,766

Provision for income taxes
(29,218
)
 
(3,063
)
 
(33,440
)
 
(9,055
)
Net (loss) income
$
(20,472
)

$
2,104


$
(18,542
)

$
711

Comprehensive (loss) income
$
(41,003
)
 
$
9,182

 
$
(39,482
)
 
$
2,665

 
 
 
 
 
 
 
 
Net (loss) income per share:
 
 
 
 
 
 
 
Basic
$
(1.32
)
 
$
0.14

 
$
(1.20
)
 
$
0.05

Diluted
$
(1.32
)
 
$
0.13

 
$
(1.20
)
 
$
0.05

Shares used in computing net (loss) income per share:
 
 
 
 
 
 
 
Basic
15,475,836

 
15,375,728

 
15,426,125

 
15,352,352

Diluted
15,475,836

 
16,044,291

 
15,426,125

 
15,791,597

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


4


Xerium Technologies, Inc.
Consolidated Statements of Cash Flows
(Dollars in thousands and unaudited)
 
 
Nine Months Ended
September 30,
 
2014
 
2013
Operating activities
 
 
 
Net (loss) income
$
(18,542
)
 
$
711

Adjustments to reconcile net (loss) income to net cash provided by operating activities:
 
 
 
Stock-based compensation
1,858

 
1,141

Depreciation
24,950

 
26,051

Amortization of intangibles
1,230

 
1,368

Deferred financing cost amortization
2,409

 
2,293

Foreign exchange (gain) loss on revaluation of debt
(340
)
 
1,626

Deferred taxes
1,509

 
1,339

Asset impairment
277

 
1,078

(Gain) loss on disposition of property and equipment
(4
)
 
154

Loss on extinguishment of debt

 
3,123

Provision for doubtful accounts
284

 
543

Change in assets and liabilities which provided (used) cash:
 
 
 
Accounts receivable
(5,047
)
 
(10,599
)
Inventories
(7,897
)
 
(5,195
)
Prepaid expenses
120

 
1,714

Other current assets
1,223

 
(1,026
)
Accounts payable and accrued expenses
3,587

 
7,436

Deferred and other long-term liabilities
(4,300
)
 
(1,326
)
Net cash provided by operating activities
1,317

 
30,431

Investing activities
 
 
 
Capital expenditures
(33,666
)
 
(15,562
)
Proceeds from disposals of property and equipment
163

 
2,235

Net cash used in investing activities
(33,503
)
 
(13,327
)
Financing activities
 
 
 
Proceeds from borrowings
73,579

 
199,000

Principal payments on debt
(44,834
)
 
(198,848
)
Payment of financing fees
(1,398
)
 
(3,030
)
Payment of obligations under capital leases
(634
)
 

Net cash provided by (used in) financing activities
26,713

 
(2,878
)
Effect of exchange rate changes on cash flows
(430
)
 
(221
)
Net (decrease) increase in cash
(5,903
)
 
14,005

Cash and cash equivalents at beginning of period
25,716

 
34,777

Cash and cash equivalents at end of period
$
19,813

 
$
48,782

 
 
 
 
Non-cash capitalized lease asset and liability
$
4,468

 
$

Accrued construction in process
$
2,400

 
$




5


Xerium Technologies, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands, except per share data)

1. Description of Business and Significant Accounting Policies
Description of Business

Xerium Technologies, Inc. (the "Company") is a leading global provider of industrial consumables and mechanical services used in the production of paper, paperboard, building products and nonwoven materials. Its operations are strategically located in the major paper-making regions of the world, including North America, Europe, South America and Asia-Pacific.
Basis of Presentation
The accompanying unaudited condensed consolidated interim financial statements at September 30, 2014 and for the three and nine months ended September 30, 2014 and 2013 include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) for interim financial reporting and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, such financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. The interim results presented herein are not necessarily indicative of the results to be expected for the entire year. In management’s opinion, these unaudited condensed consolidated interim financial statements contain all adjustments of a normal recurring nature necessary for a fair presentation of the financial statements for the interim periods presented. These unaudited consolidated interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2013 as reported on the Company's Annual Report on Form 10-K filed on March 4, 2014.
Accounting Policies
Inventories, net
Inventories are generally valued at the lower of cost or market using the first-in, first-out (FIFO) method. Raw materials are valued principally on a weighted average cost basis. The Company’s work in process and finished goods are specifically identified and valued based on actual inputs to production. Provisions are recorded as appropriate to write-down obsolete and excess inventory to estimated net realizable value. The process for evaluating obsolete and excess inventory often requires management to make subjective judgments and estimates concerning future sales levels, quantities and prices at which such inventory will be able to be sold in the normal course of business, while considering the general aging of inventory and factoring in any new business conditions.
The components of inventories are as follows at:
 
 
September 30,
2014
 
December 31,
2013
Raw materials
$
19,266

 
$
22,009

Work in process
31,452

 
28,414

Finished goods (includes consigned inventory of $8,339 at September 30, 2014 and $8,697 at December 31, 2013)
42,801

 
41,845

Inventory allowances
(7,077
)
 
(8,338
)
 
$
86,442

 
$
83,930

Goodwill
The Company accounts for goodwill and other intangible assets in accordance with ASC Topic 350, Intangibles—Goodwill and Other Intangible Assets (“Topic 350”). Topic 350 requires that goodwill and intangible assets that have indefinite lives not be amortized, but instead, must be tested for impairment at least annually or whenever events or business conditions warrant. During the three months ended September 30, 2014, the Company evaluated events and business conditions to determine if a test for an impairment of goodwill was warranted. No such events or business conditions took place during this period, therefore no test was determined to be warranted at September 30, 2014.
Warranties

6


The Company offers warranties on certain roll products that it sells. The specific terms and conditions of these warranties vary depending on the product sold, the country in which the product is sold and arrangements with the customer. The Company estimates the costs that may be incurred under its warranties and records a liability in Accrued Expenses on its Consolidated Balance Sheet for such costs. Factors that affect the Company’s warranty liability include the number of units sold, historical and anticipated rates of warranty claims, cost per claim and new product introduction. The Company periodically assesses the adequacy of its recorded warranty claims and adjusts the amounts as necessary. The table below represents the changes in the Company’s warranty liability for the nine months ended September 30, 2014:
 
Beginning Balance
 
Charged to
 Cost
of Sales
 
Effect of Foreign
Currency
Translation
 
Deduction
from
Reserves
 
Ending Balance
For the nine months ended September 30, 2014
$
1,629

 
$
1,694

 
$
(86
)
 
$
(867
)
 
$
2,370


Net Income Per Common Share
Net income per common share has been computed and presented pursuant to the provisions of ASC Topic 260, Earnings per Share (“Topic 260”). Net income per share is based on the weighted-average number of shares outstanding during the period. As of September 30, 2014 and 2013, the Company had outstanding restricted stock units (“RSUs”), deferred stock units (“DSUs”) and options.
The following table sets forth the computation of basic and diluted weighted-average shares:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Weighted-average common shares outstanding–basic
15,475,836

 
15,375,728

 
15,426,125

 
15,352,352

Dilutive effect of stock-based compensation awards outstanding

 
668,563

 

 
439,245

Weighted-average common shares outstanding–diluted
15,475,836

 
16,044,291

 
15,426,125

 
15,791,597

Dilutive securities aggregating 1.3 million were outstanding for the three and nine months ended September 30, 2014, but were not included in the computation of diluted earnings per share for the three and nine months ended September 30, 2014, because the Company had net losses for both periods and the impact of including such shares would be anti-dilutive to the earnings per share calculations.
Dilutive securities aggregating 1.7 million and 2.0 million were outstanding for the three and nine months ended September 30, 2013, but were not included in the computation of diluted earnings per share for the three and nine months ended September 30, 2013, primarily due to the warrants outstanding, which had an exercise price that exceeded the Company's average stock price for both periods.

Impairment
The Company reviews its long-lived assets that have finite lives for impairment in accordance with ASC Topic 360, Property, Plant, and Equipment (“Topic 360”). This topic requires that companies evaluate the fair value of long-lived assets based on the anticipated undiscounted future cash flows to be generated by the assets when indicators of impairment exist to determine if there is impairment to the carrying value. Any change in the carrying amount of an asset as a result of the Company's evaluation has been recorded in either restructuring expense, if it was a result of the Company's restructuring activities, or general and administrative expense for all other impairments in the consolidated statements of operations. Impairment charges associated with restructuring are discussed in Note 7 "Restructuring Expense". For the nine months ended September 30, 2014 and 2013, the Company had $0.3 million and $0.4 million of impairment charges included in restructuring expense, respectively.

In addition, in 2013, the Company determined there was an impairment of $0.7 million to the carrying value of a vacant facility held for sale and certain other assets at March 31, 2013. This impairment charge is included in general and administrative expense in the Consolidated Statements of Operations for the nine months ended September 30, 2013. The facility and related assets were sold during the third quarter of 2013.
Reclassifications


7


During the first quarter of 2014, while implementing a new financial reporting system, the Company redesigned its chart of accounts in order to provide more consistent internal and external reporting globally. In addition to this change, the Company's corporate management organizational structure was changed from primarily a geographic regional management organization to a more centralized functional management organization. These changes drove certain changes in the mappings of the related accounts in the chart of accounts. As these changes are reflected in the 2014 consolidated financial statements, these changes resulted in reclassifications in both the Consolidated Balance Sheet at December 31, 2013 and the Consolidated Statement of Operations for the three and nine months ended September 30, 2013. Management performed a SAB 99 "Materiality" analysis on these reclassifications, and determined the only reclassification material to the Company's consolidated financial statements as a whole was a $0.5 million and a $1.7 million reclassification from research and development expenses to selling expenses as a result of moving certain personnel from the research and development department to the selling department. This reclassification has been made in the Consolidated Statement of Operations for the three and nine months ended September 30, 2013

New Accounting Pronouncements

In May of 2014, the FASB issued Accounting Standard Update No. 2014-09 Revenue from Contracts with Customers ("ASU 2014-09"). ASU 2014-09 requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company identify the contract with the customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract and recognize revenue when it satisfies the performance obligations. The Company will also be required to disclose information regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is required to be adopted in January of 2017. Retrospective application is required either to all periods presented or with the cumulative effect of initial adoption recognized in the period of adoption. The Company is in the process of evaluating this accounting standard update.

In June 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-12, “Compensation - Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.” The amendments in this update require that a performance target that affects vesting and that could be achieved after the requisite service period should be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. ASU 2014-12 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this standard is not expected to have an impact on the Company’s financial position or results of operations.

In August of 2014 the FASB issued Accounting Standard Update 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern ("ASU 2014-15"). ASU 2014-15 is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. For all entities, the ASU is effective for annual periods ending after 15 December 2016 and interim periods within annual periods beginning after 15 December 2016. Early adoption is permitted. The Company does not expect that this standard will have an impact on the Company's Consolidated Financial Statements.
2. Derivatives and Hedging
As required by ASC Topic 815, Derivatives and Hedging (“Topic 815”), the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability or firm commitment attributable to a particular risk are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.
Risk Management Objective of Using Derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core

8


business activities. From time to time, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known cash amounts, the value of which are determined by interest rates or foreign exchange rates.
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate caps as part of its interest rate risk management strategy. Interest rate caps designated as cash flow hedges protect the Company from increases in interest rates above the strike rate of the interest rate cap. At September 30, 2014, the Company had no interest rate swaps. Therefore, the financial statements were not exposed to the effects of interest rate fluctuations and these did not have a material impact on its results of operations.
Non-designated Hedges of Foreign Exchange Risk
Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to foreign exchange rates, but do not meet the strict hedge accounting requirements of Topic 815. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.
The Company, from time to time, may enter into foreign exchange forward contracts to fix currencies at specified rates based on expected future cash flows to protect against the fluctuations in cash flows resulting from sales denominated in foreign currencies. Additionally, to manage its exposure to fluctuations in foreign currency on intercompany balances and certain purchase commitments, the Company from time to time may use foreign exchange forward contracts.
As of September 30, 2014 and December 31, 2013, the Company had outstanding derivatives that were not designated as hedges in qualifying hedging relationships. The value of these contracts is recognized at fair value based on market exchange forward rates and is recorded in other assets or other liabilities on the Consolidated Balance Sheets. The following represents the fair value of these derivatives at September 30, 2014 and December 31, 2013 and the change in fair value included in foreign exchange gain in the three and nine months ended September 30, 2014 and 2013:
 
September 30, 2014
 
December 31, 2013
Fair value of derivative (liability) asset
$
(185
)
 
$
530

 
Three Months Ended
September 30, 2014
 
Three Months Ended
September 30, 2013
Change in fair value of derivative included in foreign exchange (loss) gain
$
(123
)
 
$
(836
)
 
Nine Months Ended September 30, 2014
 
Nine Months Ended September 30, 2013
Change in fair value of derivative included in foreign exchange (loss) gain
$
(1,328
)
 
$
706


The following represents the notional amounts of foreign exchange forward contracts at September 30, 2014:
 
 
Notional Sold
 
Notional Purchased  

Non-designated hedges of foreign exchange risk
$
22,777

 
$
(33,508
)
Fair Value of Derivatives Under ASC Topic 820
ASC Topic 820, Fair Value Measurements and Disclosures (“Topic 820”), emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, Topic 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or

9


liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs including fair value of investments that do not have the ability to redeem at net asset value as of the measurement date, or during the first quarter following the measurement date. The derivative assets or liabilities are typically based on an entity’s own assumptions, as there is little, if any, market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and the Company considers factors specific to the asset or liability. The Company determined that its derivative valuations, which are based on market exchange forward rates, fall within Level 2 of the fair value hierarchy.

3. Long-term Debt
At September 30, 2014 and December 31, 2013, long-term debt consisted of the following:
 
September 30, 2014
 
December 31, 2013
Senior secured term loan facility, payable quarterly, U.S. Dollar denominated–LIBOR
(minimum 1.25%) plus 4.50% (5.75%) net of $0.9 million discount. Matures May of 2019.
$
226,577

 
$
198,000

Senior Notes (Unsecured), payable semi-annually–U.S. Dollar denominated interest rate fixed at 8.875%, matures June of 2018
236,410

 
236,410

Other long term debt
659

 
462

 
463,646

 
434,872

Less current maturities
2,362

 
2,166

Total
$
461,284


$
432,706

           
On May 17, 2013, the Company entered into a Credit and Guaranty Agreement for a $200.0 million term loan credit facility (the “Term Credit Facility”), net of a discount of $1.0 million, among the Company, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions. The Company also entered into a Revolving Credit and Guaranty Agreement originally for a $40.0 million asset-based revolving credit facility subject to a borrowing base among the Company, Xerium Canada Inc., as Canadian borrower, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions (the "Domestic Revolver"). On March 3, 2014, the Company entered into an amendment to the Revolving Credit and Guaranty Agreement (as amended, the “ABL Facility,” and collectively with the Term Credit Facility, the “Credit Facility”) to add the Company's German subsidiaries as European Borrowers (the "European Borrowers") and to provide for an additional $15 million European asset-based revolving credit facility subject to a European borrowing base (the "European Revolver"), increasing the aggregate availability under the ABL Facility to $55 million.
The Term Credit Facility provides for:
a six-year $200 million senior secured term loan facility, provided the facility would mature in March 2018 if any of the Company's 8.875% senior unsecured notes due 2018 in the aggregate principal amount of $240 million (the “Notes”) remain outstanding at that time;
an accordion option (the “Incremental Facility”) allowing for increases for borrowings under the Term Credit Facility with the same terms, and borrowing of new tranches of term loans, up to an aggregate principal amount equal to (i) $75 million plus (ii) an additional amount (the “Facility Increase”) provided, if after giving effect to such Facility Increase (as well as any other additional term loans), on a pro forma basis, the Senior Secured Leverage Ratio (as defined in the Term Credit Facility) for the most recent four consecutive fiscal quarters does not exceed 2.25:1; and
in connection with the amendment to the ABL Facility, the Term Credit Facility was amended to permit the ABL Facility to be further increased by an additional $10 million, to a total aggregate availability of not more than $65 million, provided that if the ABL Facility is increased beyond $55 million, certain baskets for additional indebtedness and liens otherwise available to the Company under the Term Loan Facility will be reduced dollar-for-dollar by any additional increase to the ABL Facility.
On August 18, 2014, the Company entered into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”). Under the Second Amendment, the Company borrowed an additional $30.0 million by utilizing the Incremental Facility. The $30 million in additional borrowings was used to finance a tax amnesty payment in Brazil. See Note 4, Income Taxes, for a discussion of the Company's participation in a tax amnesty program in Brazil. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility.

10


The Domestic Revolver provides for a $40 million senior secured revolving credit facility with a $20 million sub-limit on letters of credit. The European Revolver provides for a $15 million senior secured revolving credit facility with a $10 million sub-limit on letters of credit. Availability under the Domestic Revolver is subject to a borrowing base that is based on a specified percentage of eligible accounts receivable and inventory. Availability under the European Revolver is subject to a borrowing base that is based on a specified percentage of eligible accounts receivable, inventory and property and equipment. The term of the ABL Facility is five years, provided that if any of the Notes remain outstanding in March 2018, the ABL Facility would mature at that time.
The interest rates under the Term Credit Facility are calculated, at the Company's option, at either the base rate or LIBOR, plus a margin of 4.00% and 5.00%, respectively. Each of the base rate and LIBOR is subject to a minimum of 2.25% and 1.25%, respectively. If the Company's Senior Secured Leverage Ratio (as defined in the Credit Facility) is less than 2.00:1 at any quarterly determination date, then the margins over the base rate and LIBOR will be 3.50% and 4.50%, respectively.
Depending on whether advances are made in U.S. Dollars or Canadian Dollars, interest rates under the Domestic Revolver are calculated, at our option, at either a U.S.-based or Canadian-based base rate ("Base Rate Loans") or LIBOR or the Canadian Dealer Offered Rate ("CDOR") (each, "Fixed Rate Loans"), respectively, plus a margin of 0.75% for Base Rate Loans and a margin of 1.75% for Fixed Rate Loans. If we draw advances on the Domestic Revolver that are equal to or greater than 33.3% but less 66.7% of the $40 million limit, then the margins on Base Rate Loans and Fixed Rate Loans increase to 1.00% and 2.00%, respectively. The margins rise to 1.25% and 2.25%, respectively, if advances under the Domestic Revolver are equal to or greater than 66.7% of the $40 million limit. Interest rates under the European Revolver are calculated, at either LIBOR or Overnight LIBOR, plus a margin of 1.75%. If the European Borrowers draw advances on the European Revolver that are equal to or greater than 33.3% but less than 66.7% of the $15 million limit, then the margin increases to 2.00%. The margin rises to 2.25% if advances under the European Revolver are equal to or greater than 66.7% of the $15 million limit. In addition to paying interest on outstanding advances under the ABL Facility, we are required to pay a commitment fee to the lenders in respect of the unutilized commitments at a rate equal to 0.50% per annum if advances under the ABL Facility are less than or equal to 50% of the commitments or a rate equal to 0.375% per annum if advances under the ABL are more than 50% of the commitments.
The obligations under the Credit Facility are guaranteed by all of our existing and future direct and indirect subsidiaries that are organized in the United States, and, in the case of the European Revolver, by each other European Borrower, certain other of the Company's European subsidiaries and any existing or future direct or indirect subsidiaries that become a party to the ABL Facility.
The Credit Facility contains certain customary covenants that, subject to exceptions, restrict the Company's ability to, among other things:
declare dividends or redeem or repurchase equity interests;
prepay, redeem or purchase debt;
incur liens and engage in sale-leaseback transactions;
make loans and investments;
incur additional indebtedness;
amend or otherwise alter debt and other material agreements;
make capital expenditures in excess of $42 million per fiscal year, subject to adjustment;
engage in mergers, acquisitions and asset sales;
transact with affiliates; and
engage in businesses that are not related to the Company's existing business.
The Credit Facility eliminates the interest coverage and leverage coverage ratio maintenance tests that were contained in the Company's 2011 Credit Facility. However, the ABL Facility contains a springing Fixed Charge Coverage Ratio (as defined in the ABL Facility), which must be not less than 1.00:1 during periods in which our Global Excess Availability (as defined in the ABL Facility) falls below certain minimum thresholds.
On May 26, 2011, the Company completed a refinancing transaction, which replaced certain of its then outstanding indebtedness with the senior unsecured notes payable semi-annually, bearing interest at 8.875% per annum (the "Notes"). The Notes contain customary covenants that, subject to certain exceptions, restrict its ability to enter into certain transactions and engage in certain activities. The Company has $236.4 million aggregate principal amount outstanding as of September 30, 2014 under the Notes.
As of September 30, 2014, the outstanding balance of the Company's term debt under its Credit Facility and Notes was $463.0 million, which is net of a $0.9 million discount. In addition, as of September 30, 2014, an aggregate of $37.1 million is available for additional borrowings under the ABL Facility. This availability represents a borrowing base of $47.5 million under the ABL Facility less $10.4 million of that facility committed for letters of credit or additional borrowings. Additionally, at September 30, 2014, the Company had approximately $4.7 million available for borrowings under other small lines of credit.

11



As of September 30, 2014 and December 31, 2013, the carrying value of the Company’s long-term debt was $463.6 million and $434.9 million, respectively, and its fair value was approximately $480.3 million and $451.6 million, respectively. The Company determined the fair value of its debt utilizing significant other observable inputs (Level 2 of the fair value hierarchy).

Capitalized Lease Liabilities

As of September 30, 2014, the Company had capitalized lease liabilities totaling $4.1 million. These amounts represent the lease on the corporate headquarters and a software licensing agreement.

4. Income Taxes

The Company utilizes the liability method for accounting for income taxes in accordance with ASC Topic 740, Income Taxes (“Topic 740”). Under Topic 740, deferred tax assets and liabilities are determined based on the difference between their financial reporting and tax basis. The assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reduces its deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In making this determination, the Company evaluates all available information including the Company’s financial position and results of operations for the current and preceding years, as well as any available projected information for future years.
For the three and nine months ended September 30, 2014, the provision for income taxes was $29,218 and $33,440 as compared to $3,063 and $9,055 for the three and nine months ended September 30, 2013. The increase in tax expense was primarily attributable to settling a tax assessment in Brazil, as well as the geographic mix of earnings for those periods in the three and nine months ended September 30, 2014. Generally, in the absence of a large settlement such as the Brazil tax settlement which occurred during the three months ended September 30, 2014, the provision for income taxes is primarily impacted by income earned in tax paying jurisdictions relative to income earned in non-tax paying jurisdictions. The majority of income recognized for purposes of computing the effective tax rate is earned in countries where the statutory income tax rates range from 15.0% to 39.4%; however, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. The Company generates losses in certain jurisdictions for which no tax benefit is realized, as the deferred tax assets in these jurisdictions (including the net operating losses) are fully reserved in the valuation allowance. For this reason, the Company recognizes minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States, the United Kingdom and Australia. Due to these reserves, the geographic mix of the Company’s pre-tax earnings has a direct correlation with how high or low its annual effective tax rate is relative to consolidated earnings. As the Company continues to reorganize and restructure its operations, it is possible that deferred tax assets, for which no income tax benefit has previously been provided, may more likely than not become realized. The Company continues to evaluate future operations and will record an income tax benefit in the period where it believes it is more likely than not that the deferred tax asset will be able to be realized.
As of September 30, 2014, the Company had a gross amount of unrecognized tax benefit of $8,441, exclusive of interest and penalties. The unrecognized tax benefit increased by approximately $467 and $949 during the three and nine months ended September 30, 2014, as a result of foreign currency effects, statute expirations, and ongoing changes in currently reserved positions as a result of new facts or information. The Company’s policy is to recognize interest and penalties related to income tax matters as income tax expense, which were $140 and $263 related to the unrecognized tax benefits for the three and nine months ended September 30, 2014. The tax years 2000 through 2013 remain open to examination in a number of the major tax jurisdictions to which the Company and its subsidiaries are subject. The Company believes that it has made adequate provisions for all income tax uncertainties.
In July of 2013, FASB issued ASU 2013-11 Income Taxes (Topic 740), Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Taskforce) ("ASU 2013-11"). Beginning January 1, 2014, the effective date of this regulation, the Company has adopted the provisions of ASU 2013-11 related to presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists.  The effect on the date of adoption resulted in a decrease in other long term liabilities and a decrease in other assets of $1,147 related to uncertain tax benefits for Canada, Germany, and Italy.
In November of 2011, the Federal Revenue Department of the Ministry of Finance of Brazil (“FRD”) issued a tax assessment against the Company’s indirect subsidiary, Xerium Technologies Brasil Indústria e Comércio S.A. (“Xerium Brazil”), challenging the goodwill recorded in the 2005 acquisition of Wangner Itelpa and Huyck Indústria e Comércio S.A. by

12


Robec Brasil Participações Ltda., a predecessor to Xerium Brazil. This assessment denied the amortization of that goodwill against net income for the years 2006 through 2010 and sought payment of approximately $39,656 (subject to currency exchange rates) in tax, penalties and interest. 
During the three months ended September 30, 2014, the Company chose to participate in an amnesty program offered by the FRD that was open to taxpayers until August 25, 2014. The amnesty program offered significant reductions in the penalties and interest initially assessed against the Company. By paying a lump sum amount, the Company received a reduction of 100% of the penalties assessed and a 45% reduction of interest accrued on the tax assessment relating to tax years 2006 through 2010. Because tax amnesty and voluntary disclosure programs were open for tax years beyond the time period of the Company's particular assessment, the Company also included in its payment to the Brazilian government amounts relating to tax years 2011 through 2013, which corresponded to the same tax deductions under review in the assessment for tax years 2006 through 2010. Additionally, the Company has adjusted the tax calculations for 2014 to exclude the same tax deductions which were under review, and the Company adjusted its tax payments related to tax year 2014 accordingly. In August of 2014, the Company settled the assessed and unassessed tax debts with the Brazilian government by paying principal and interest totaling $18,254 and $6,724, respectively. The settlement had no impact on the Company's unrecognized tax benefits during the three months ended September 30, 2014. As previously discussed in Note 3, the Company borrowed an additional $30.0 million under its Incremental Facility to fund this tax settlement payment.
5. Pensions, Other Post-retirement and Post-employment Benefits
The Company accounts for its pensions, other post-retirement and post-employment benefit plans in accordance with ASC Topic 715, Compensation—Retirement Benefits (“Topic 715”). The Company has defined benefit pension plans covering substantially all of its U.S. and Canadian employees and employees of certain subsidiaries in other countries. Benefits are generally based on the employee’s years of service and compensation. These plans are funded in conformity with the funding requirements of applicable government regulations. The Company does not fund certain plans, as funding is not required. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. In addition, the Company also intends to fund its U.K. and Canadian defined benefit plans in accordance with local regulations.
As required by Topic 715, the following tables summarize the components of net periodic benefit cost:
Defined Benefit Plans
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Service cost
$
1,029

 
$
934

 
$
2,720

 
$
2,873

Interest cost
2,080

 
1,497

 
5,500

 
4,605

Expected return on plan assets
(1,972
)
 
(1,356
)
 
(5,213
)
 
(4,169
)
Amortization of prior service cost

 
7

 

 
10

Amortization of net loss
371

 
547

 
981

 
1,690

Net periodic benefit cost
$
1,508

 
$
1,629

 
$
3,988

 
$
5,009

6. Comprehensive (Loss) Income and Accumulated Other Comprehensive Loss
Comprehensive (loss) income for the three and nine months ended September 30, 2014 (pension liability changes net of tax benefits of $(268) and $235, respectively) and 2013 (pension liability changes net of tax benefits of $74 and $(96), respectively) is as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net (loss) income
$
(20,472
)
 
$
2,104

 
$
(18,542
)
 
$
711

Foreign currency translation adjustments
(21,902
)
 
7,462

 
(22,216
)
 
(650
)
Pension liability changes under Topic 715
1,338

 
(398
)
 
1,190

 
2,217

Change in value of derivative instruments
33

 
14

 
86

 
387

Comprehensive (loss) income
$
(41,003
)
 
$
9,182

 
$
(39,482
)
 
$
2,665


13


The components of accumulated other comprehensive loss for the three months ended September 30, 2014 are as follows (net of tax benefits of $5,299):
 
Foreign
Currency
Translation    
Adjustment
 
Pension
Liability
Changes Under 
Topic 715
 
Change in
Value of
Derivative
Instruments   
 
Accumulated   
Other
Comprehensive
(Loss) Income
Balance at June 30, 2014
$
(450
)
 
$
(29,829
)
 
$
(182
)
 
$
(30,461
)
Other comprehensive income before reclassifications
(21,902
)
 
967

 

 
(20,935
)
Amounts reclassified from other comprehensive income
 
 
 
 
 
 
 
    Amortization of actuarial losses

 
371

 

 
371

    Amortization of interest expense

 

 
33

 
33

Net current period other comprehensive income
(21,902
)
 
1,338

 
33

 
(20,531
)
Balance at September 30, 2014
$
(22,352
)
 
$
(28,491
)
 
$
(149
)
 
$
(50,992
)
 
 
 
 
 
 
 
 
The components of accumulated other comprehensive loss for the nine months ended September 30, 2014 are as follows (net of tax benefits of $5,299):
 
Foreign
Currency
Translation    
Adjustment
 
Pension
Liability
Changes Under 
Topic 715
 
Change in
Value of
Derivative
Instruments   
 
Accumulated   
Other
Comprehensive
(Loss) Income
Balance at December 31, 2013
$
(136
)
 
$
(29,681
)
 
$
(235
)
 
$
(30,052
)
Other comprehensive income before reclassifications
(22,216
)
 
209

 

 
(22,007
)
Amounts reclassified from other comprehensive income
 
 
 
 
 
 
 
    Amortization of actuarial losses

 
981

 

 
981

    Amortization of interest expense

 

 
86

 
86

Net current period other comprehensive income
(22,216
)
 
1,190

 
86

 
(20,940
)
Balance at September 30, 2014
$
(22,352
)
 
$
(28,491
)
 
$
(149
)
 
$
(50,992
)
 
 
 
 
 
 
 
 
For the three and nine months ended September 30, 2014, the amortization of actuarial losses is included in cost of products sold and general and administrative expenses in the Consolidated Statements of Operations.
For the three and nine months ended September 30, 2014, the foreign currency translation adjustments of $(21,902) and $(22,216) were primarily the result of the decline in the Euro and Brazilian Real and the effect of that decline on our foreign subsidiaries net equity balances of $132 million and $148 million in Europe and Brazil, respectively. The Euro declined to $1.269 at September 30, 2014 from $1.361 at June 30, 2014 and $1.378 at December 31, 2013. The Brazilian Real declined to $0.412 at September 30, 2014 from $0.453 at June 30, 2014 and $0.423 at December 31, 2013.

7. Restructuring and Impairment Expense
For the nine months ended September 30, 2014, the Company incurred restructuring expenses of $15.7 million. These charges were related to $4.2 million in headcount reductions, $3.7 million of charges related to the closure of the Heidenheim rolls facility, $3.0 million in severance and other charges due to the final negotiated severance package at the Joao Pessoa, Brazil clothing facility, a $1.6 million charge in Italy to terminate a sales agency contract, $1.4 million in severance charges relating to the closure of the Argentina press felt facility, $0.7 million of charges to move certain equipment from the closed

14


France rolls facility to China and other locations in Europe, $0.3 million of costs associated with liquidating the Vietnam facility, and $0.8 million in severance and facility charges relating to the Spain closure. For the nine months ended September 30, 2013, the Company incurred restructuring expenses of $8.5 million. These included charges relating to headcount reductions, the closure of two clothing facilities in Spain and Argentina and the closure of a roll cover facility in Charlotte, NC.
The following table sets forth the significant components of the restructuring accrual (included in Accrued Expenses on our Consolidated Balance Sheet), including activity under restructuring programs for the nine months ended September 30, 2014 and 2013:
  
 
Balance at
December 31, 
2013
 
Charges (1)
 
Currency    
Effects
 
Cash
Payments    
 
Balance at
September 30, 2014
Severance and other benefits
$
6,466

 
$
11,737

 
$
(559
)
 
$
(11,884
)
 
$
5,760

Facility costs and other
1,468

 
3,698

 
(176
)
 
(2,963
)
 
2,027

Total
$
7,934

 
$
15,435

 
$
(735
)
 
$
(14,847
)
 
$
7,787

 
 
Balance at
December 31, 
2012
 
Charges (2)
 
Currency    
Effects
 
Cash
Payments    
 
Balance at
September 30, 2013
Severance and other benefits
$
15,577

 
$
5,743

 
$
(53
)
 
$
(11,028
)
 
$
10,239

Facility costs and other
335

 
2,302

 
103

 
(1,880
)
 
860

Total
$
15,912

 
$
8,045

 
$
50

 
$
(12,908
)
 
$
11,099

(1) Amount excludes $277 impairment charges.
(2) Amount excludes $409 impairment charges.
Restructuring and impairment expense by segment, which is not included in Segment Earnings in Note 8, is as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Clothing
$
2,168

 
$
2,888

 
$
10,273

 
$
6,875

Roll Covers
1,272

 
86

 
5,310

 
1,518

Corporate
26

 
60

 
129

 
61

Total
$
3,466

 
$
3,034

 
$
15,712

 
$
8,454


8. Business Segment Information
The Company is a global manufacturer and supplier of consumable products used primarily in the production of paper and is organized into two reportable segments: Clothing and Roll Covers. The Clothing segment represents the manufacture and sale of synthetic textile belts used to transport paper along the length of papermaking machines. The Roll Covers segment primarily represents the manufacture and refurbishment of covers used on the steel rolls of papermaking machines and the servicing of those rolls. The Company manages each of these operating segments separately.
Management evaluates segment performance based on earnings before interest, taxes, depreciation and amortization and before allocation of corporate charges. Such measure is then adjusted to exclude items that are of an unusual nature and are not used in measuring segment performance or are not segment specific (“Segment Earnings (Loss)”). The accounting policies of these segments are the same as those for the Company as a whole. Inter-segment net sales and inter-segment eliminations are not material for any of the periods presented.
Summarized financial information for the Company’s reportable segments is presented in the tables that follow for the three and nine months ended September 30, 2014 and 2013.

15


 
Clothing       
 
Roll
Covers        
 
Corporate     
 
Total
Three Months Ended September 30, 2014:
 
 
 
 
 
 
 
Net Sales
$
86,085

 
$
52,773

 
$

 
$
138,858

Segment Earnings (Loss)
$
20,244

 
$
13,486

 
$
(2,266
)
 

Three Months Ended September 30, 2013:
 
 
 
 
 
 
 
Net Sales
$
87,980

 
$
47,062

 
$

 
$
135,042

Segment Earnings (Loss)
$
20,405

 
$
11,140

 
$
(4,332
)
 


 
 
 
 
 
 
 
 
Nine Months ended September 30, 2014:
 
 
 
 
 
 
 
Net Sales
$
264,561

 
$
147,404

 
$

 
$
411,965

Segment Earnings (Loss)
$
58,839

 
$
32,868

 
$
(5,121
)
 
 
Nine Months ended September 30, 2013:
 
 
 
 
 
 
 
Net Sales
$
267,331

 
$
145,840

 
$

 
$
413,171

Segment Earnings (Loss)
$
58,615

 
$
35,802

 
$
(11,162
)
 
 
Provided below is a reconciliation of Segment Earnings (Loss) to income before provision for income taxes for the three and nine months ended September 30, 2014 and 2013, respectively.
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Segment Earnings:
 
 
 
 
 
 
 
Clothing
$
20,244

 
$
20,405

 
$
58,839

 
$
58,615

Roll Covers
13,486

 
11,140

 
32,868

 
35,802

Corporate
(2,266
)
 
(4,332
)
 
(5,121
)
 
(11,162
)
Stock-based compensation
(709
)
 
(547
)
 
(1,858
)
 
(1,141
)
Inventory write-off

 

 

 
(692
)
Impairment expense

 

 

 
(667
)
Interest expense, net
(9,412
)
 
(9,378
)
 
(26,985
)
 
(31,697
)
Depreciation and amortization
(8,594
)
 
(8,791
)
 
(26,180
)
 
(27,419
)
Restructuring expense
(3,466
)
 
(3,034
)
 
(15,712
)
 
(8,454
)
Loss on debt extinguishment

 

 

 
(3,123
)
Plant startup costs
(537
)
 
(296
)
 
(953
)
 
(296
)
Income before provision for income taxes
$
8,746

 
$
5,167

 
$
14,898

 
$
9,766


9. Commitments and Contingencies
The Company is involved in various legal matters which have arisen in the ordinary course of business as a result of various immaterial labor claims, taxing authority reviews and other routine legal matters. As of September 30, 2014, the Company accrued an immaterial amount in its financial statements for these matters for which the Company believed the possibility of loss was probable and was able to estimate the damages. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its financial position, results of operations or cash flow. The Company believes that any additional liability in excess of amounts provided which may result from the resolution of legal matters will not have a material adverse effect on the financial condition, liquidity or cash flow of the Company.

10. Stock-Based Compensation and Stockholders’ Deficit
The Company records stock-based compensation expense in accordance with ASC Topic 718, Accounting for Stock Compensation and has used the straight-line attribution method to recognize expense for time-based restricted stock units ("RSUs") and deferred stock units ("DSUs"). The Company recorded stock-based compensation expense during the three and nine months ended September 30, 2014 and September 30, 2013 as follows: 

16


 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2014
 
2013
 
2014
 
2013
RSU, Options and DSU Awards (1)
 
$
709

 
$
547

 
$
1,858

 
$
1,141

 
(1)
Related to RSUs, Options and DSUs awarded to certain employees and non-employee directors.
 
Summary of Activity under the Long-Term Incentive Plans

On May 8, 2012, the Board approved the 2012 Executive Long-Term Incentive Plan (the “2012 Executive LTIP”) under the 2010 Equity Incentive Plan (the "2010 Plan"). Awards under the 2012 Executive LTIP are both time-based and performance-based. A specific target share award is set for each participant in the 2012 Executive LTIP. Awards will be paid in the form of RSUs or shares of common stock of the Company. Time-based awards, or 50% of the total target award, were granted in the form of 54,750 time-based RSUs under the Company’s 2010 Plan. At March 31, 2014, 15,416 time-based RSUs vested in accordance with the 2012 Executive LTIP and were converted to common stock, net of applicable tax withholdings. The remaining one-third of the time-based RSUs will vest on March 31, 2015, and convert into shares of common stock as they vest. Performance-based awards, which constitute 50% of the total award, will be determined based on the Company’s performance against a three-year cumulative Adjusted EBITDA metric, adjusted for currency fluctuations during the term of the 2012 – 2014 Executive LTIP. The performance-based awards will convert into shares of the Company’s common stock and be paid after the close of the three-year performance period. The amount of the payment will be based on a sliding scale ranging from 50% if the metric is achieved at 85% of the target up to 200% if the metric is achieved at or above 115% of the target.

On June 13, 2013, at the 2013 Annual Meeting of Stockholders of Xerium Technologies, Inc., the stockholders of the Company approved an amendment to the 2010 Plan, which increased the aggregate number of shares of the Company’s common stock that may be delivered under or in satisfaction of awards under such plan from 913,525 to 1,663,525, increased the number of shares that may be subject to option and stock appreciation right grants and that may be granted as stock awards to any one participant in a calendar year from 150,000 to 500,000, and set a maximum cash award that may be granted to any one participant in a calendar year at $2,000. This amendment was approved by the Company’s Board of Directors on March 12, 2013.

After the stockholders' approval of the amendment to the 2010 Plan, awards approved by the Board were issued under the 2013 Executive Long-Term Incentive Plan (the "2013 Executive LTIP") under the 2010 Plan. Awards under the 2013 Executive LTIP are both time-based and market-based and will be paid in the form of RSUs or shares of common stock of the Company. Time-based awards, or 50% of the total target award, were granted in the form of 179,571 time-based RSUs under the Company’s 2010 Plan. These time-based awards will cliff vest on March 11, 2016, and will be converted to common stock, net of applicable tax withholdings. The market-based awards, which constitute the remaining 50% of the total award, have vested based on the Company’s stock price performance during the three year participant service period from March 11, 2013 through March 10, 2016. Vested awards will convert into shares of the Company’s common stock and be paid after the close of the three-year performance period with exceptions for certain earlier issuances due to departures.

On May 8, 2014, the Board approved the granting of awards under the 2014 Executive Long-Term Incentive Plan (the "2014 Executive LTIP") under the 2010 Plan. Awards under the 2014 Executive LTIP are time-based, performance-based and market-based and will be paid in the form of RSUs or shares of common stock of the Company. Time-based awards, or 35% of the total award, were granted in the form of 60,339 time-based RSUs under the Company’s 2010 Plan. These time-based awards will cliff vest on May 8, 2016, and will be converted to common stock, net of applicable tax withholdings.

The performance-based awards, which constitute 32.5% of the total award, were granted in the form of 56,029 performance-based RSUs under the Company’s 2010 Plan. These awards will vest based on a targeted Adjusted EBITDA performance. The targeted Adjusted EBITDA performance portion of the award measures the Company’s performance against a three-year cumulative Adjusted EBITDA metric, adjusted for currency fluctuations during the term of the 2014 – 2016 Executive LTIP. These awards will convert into shares of the Company’s common stock and be paid after the close of a three-year performance period of January 1, 2014 through December 31, 2016. The amount of the payment will range from 0% to 100% of the employee's total Adjusted EBITDA performance shares. Upon attainment of cumulative Adjusted EBITDA equal

17


to 80% or less of the target, none of the Adjusted EBITDA performance shares will vest. Upon attainment of more than 80% of the target, the adjusted EBITDA performance shares will begin vesting on a straight-line basis from 0% at 80% of the target to 100% at 100% of the target, up to a maximum payout of 100% of the Adjusted EBITDA performance shares.

The market-based awards, which constitute 32.5% of the total award, were granted in the form of 56,029 market-based RSU's under the Company's 2010 Plan. These awards will vest, based on the performance of the Company's stock against the performance of listed companies on the S&P Global Small Cap Index, on the third anniversary of the grant date, or May 8, 2017. These awards will convert into shares of the Company’s common stock and be paid after the close of the three-year performance period of May 8, 2014 through May 8, 2017. The shares that may vest will be up to 100%, with a lower threshold of a a 50% payout for 35th percentile performance and full payout at 100% for 55th percentile performance. Performance between the 35th and 55th percentile performance will result in an interpolated payout percentage between 50% and 100%.

Other Stock Compensation Plans

On August 15, 2012, the Company appointed Harold C. Bevis to the position of President and Chief Executive Officer. The Company granted Mr. Bevis a sign-on award of 204,208 restricted stock units and options to acquire 781,701 shares of the Company's common stock, par value $0.001 per share. Both the restricted stock units and the options vest over a three year period, with the first tranche having vested on August 15, 2014. The options have a 10-year term and an exercise price of $4.00 per share, the August 15, 2012 closing price of the Company's common stock on the New York Stock Exchange. On August 15, 2014, one third of Mr. Bevis's restricted stock units and options vested. Mr. Bevis received 35,562 shares of common stock, net of withholdings as a result of the restricted stock unit vesting. In addition, Mr. Bevis exercised his vested options, and received 99,189 shares of common stock, in a cashless exercise, net of withholdings.
Warrants
In 2010, the Company issued warrants exercisable into 1,663,760 shares of common stock to holders of the Company's common stock. These warrants had a term of four years and expired as of May 25, 2014. Accordingly, in May of 2014, the Company reclassified $13.5 million in warrant related charges to additional paid in capital of common stock on the Consolidated Balance Sheets to reflect the expiration of the warrants.
Directors’ Deferred Stock Unit Plan
Under the 2011 non-management directors stock plan ("2011 DSU Plan”), each director receives an annual retainer of $112, to be paid on a quarterly basis in arrears. Half of the annual retainer is payable in DSUs, with the remaining half payable in DSUs, cash or a mix of both at the election of each director. The non-management directors were awarded an aggregate of 6,229 DSUs under the 2011 DSU Plan for service during the quarter ended September 30, 2014. In addition, in accordance with the 2011 DSU Plan, 5,270 DSUs were settled in common stock during the quarter ended September 30, 2014.

11. Supplemental Guarantor Financial Information
On May 26, 2011, the Company closed on the sale of its Notes. The Notes are unsecured obligations of the Company and are fully and unconditionally guaranteed on a senior unsecured basis by all of the domestic wholly owned subsidiaries of the Company (the “Guarantors”). In accordance with Rule 3-10 of Regulation S-X promulgated under the Securities Act of 1933, as amended, the following condensed consolidating financial statements present the financial position, results of operations and cash flows of Xerium Technologies, Inc. (referred to as “Parent” for the purpose of this note only) on a stand-alone parent-only basis, the Guarantors on a Guarantors-only basis, the combined non-Guarantor subsidiaries and elimination entries necessary to arrive at the information for the Parent, the Guarantors and non-Guarantor subsidiaries on a consolidated basis.

18


Xerium Technologies, Inc.
Consolidating Balance Sheet—(Unaudited)
At September 30, 2014
(Dollars in thousands)
 
 
Parent
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
Company
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,739

 
$
(9
)
 
$
18,083

 
$

 
$
19,813

Accounts receivable, net
8

 
22,727

 
65,307

 

 
88,042

Intercompany receivables
(93,950
)
 
109,948

 
(15,998
)
 

 

Inventories, net

 
16,776

 
70,476

 
(810
)
 
86,442

Prepaid expenses
34

 
1,738

 
5,994

 

 
7,766

Other current assets

 
4,246

 
10,266

 

 
14,512

Total current assets
(92,169
)
 
155,426

 
154,128

 
(810
)
 
216,575

Property and equipment, net
15,887

 
58,920

 
237,120

 

 
311,927

Investments
742,364

 
257,859

 

 
(1,000,223
)
 

Goodwill

 
17,737

 
45,266

 

 
63,003

Intangible assets
9,605

 
1,942

 
1,125

 

 
12,672

Other assets
4

 
364

 
6,703

 

 
7,071

Total assets
$
675,691

 
$
492,248

 
$
444,342

 
$
(1,001,033
)
 
$
611,248

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
3,163

 
$
9,056

 
$
23,628

 
$

 
$
35,847

Accrued expenses
13,108

 
9,981

 
45,525

 

 
68,614

Current notes payable

 

 
7,611

 

 
7,611

Current maturities of long-term debt
2,362

 

 

 

 
2,362

Total current liabilities
18,633

 
19,037

 
76,764

 

 
114,434

Long-term debt, net of current maturities
461,284

 

 

 

 
461,284

Capitalized lease obligations
3,601

 
499

 

 

 
4,100

Deferred taxes
984

 
3,040

 
9,499

 

 
13,523

Pension, other post-retirement and post-employment obligations
10,719

 
1,132

 
49,724

 

 
61,575

Other long-term liabilities
161

 

 
7,324

 

 
7,485

Intercompany loans
272,050

 
(397,057
)
 
125,007

 

 

Total stockholders’ (deficit) equity
(91,741
)
 
865,597

 
176,024

 
(1,001,033
)
 
(51,153
)
Total liabilities and stockholders’ (deficit) equity
$
675,691

 
$
492,248

 
$
444,342

 
$
(1,001,033
)
 
$
611,248


19


Xerium Technologies, Inc.
Consolidating Balance Sheet
At December 31, 2013
(Dollars in thousands)
 
 
Parent        
 
Total
Guarantors    
 
Total Non
Guarantors    
 
Other
Eliminations
 
The
Company      
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
4,120

 
$
(10
)
 
$
21,606

 
$

 
$
25,716

Accounts receivable, net

 
22,188

 
65,764

 

 
87,952

Intercompany receivables
(112,848
)
 
110,434

 
2,414

 

 

Inventories, net

 
18,077

 
66,632

 
(779
)
 
83,930

Prepaid expenses
398

 
936

 
6,845

 

 
8,179

Other current assets
514

 
3,729

 
11,452

 

 
15,695

Total current assets
(107,816
)
 
155,354

 
174,713

 
(779
)
 
221,472

Property and equipment, net
15,794

 
59,250

 
234,620

 

 
309,664

Investments
700,697

 
284,444

 

 
(985,141
)
 

Goodwill

 
17,737

 
51,238

 

 
68,975

Intangible assets
10,964

 
3,094

 
412

 

 
14,470

Other assets
4

 

 
9,479

 

 
9,483

Total assets
$
619,643

 
$
519,879

 
$
470,462

 
$
(985,920
)
 
$
624,064

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
2,109

 
$
10,380

 
$
29,731

 
$

 
$
42,220

Accrued expenses
9,794

 
8,172

 
43,402

 

 
61,368

Current notes payable

 

 
8,267

 

 
8,267

Current maturities of long-term debt
2,024

 

 
142

 

 
2,166

Total current liabilities
13,927

 
18,552

 
81,542

 

 
114,021

Long-term debt, net of current maturities
432,706

 

 

 

 
432,706

Deferred taxes
327

 
3,040

 
12,983

 

 
16,350

Pension, other post-retirement and post-employment obligations
11,212

 
1,182

 
54,472

 

 
66,866

Other long-term liabilities
106

 
5

 
5,459

 

 
5,570

Intercompany loans
233,755

 
(355,003
)
 
121,248

 

 

Total stockholders’ (deficit) equity
(72,390
)
 
852,103

 
194,758

 
(985,920
)
 
(11,449
)
Total liabilities and stockholders’ (deficit) equity
$
619,643

 
$
519,879

 
$
470,462

 
$
(985,920
)
 
$
624,064


20


Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive (Loss) Income (Unaudited)
For the three months ended September 30, 2014
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
48,514

 
$
98,675

 
$
(8,331
)
 
$
138,858

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(225
)
 
32,320

 
59,726

 
(8,457
)
 
83,364

    Selling
394

 
5,264

 
12,537

 

 
18,195

    General and administrative
2,615

 
1,497

 
10,021

 

 
14,133

    Research and development
244

 
1,189

 
476

 

 
1,909

    Restructuring and impairment
26

 
123

 
3,317

 

 
3,466

 
3,054

 
40,393

 
86,077

 
(8,457
)
 
121,067

(Loss) income from operations
(3,054
)
 
8,121

 
12,598

 
126

 
17,791

Interest (expense) income, net
(8,842
)
 
1,367

 
(1,937
)
 

 
(9,412
)
Foreign exchange (loss) gain
(346
)
 
(60
)
 
773

 

 
367

Equity in subsidiaries income
(7,787
)
 
(18,580
)
 

 
26,367

 

(Loss) income before provision for income taxes
(20,029
)
 
(9,152
)
 
11,434

 
26,493

 
8,746

Provision for income taxes
(443
)
 
(22
)
 
(28,753
)
 

 
(29,218
)
Net loss
$
(20,472
)
 
$
(9,174
)
 
$
(17,319
)
 
$
26,493

 
$
(20,472
)
Comprehensive loss
$
(21,626
)
 
$
(9,251
)
 
$
(36,619
)
 
$
26,493

 
$
(41,003
)

Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive Income-(Unaudited)
For the three months ended September 30, 2013
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
44,922

 
$
102,702

 
$
(12,582
)
 
$
135,042

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(421
)
 
31,008

 
63,730

 
(12,661
)
 
81,656

    Selling

 
5,585

 
12,194

 

 
17,779

    General and administrative
2,485

 
1,528

 
11,265

 

 
15,278

    Research and development

 
1,337

 
508

 

 
1,845

    Restructuring and impairment
60

 
37

 
2,937

 

 
3,034

 
2,124

 
39,495

 
90,634

 
(12,661
)
 
119,592

(Loss) income from operations
(2,124
)
 
5,427

 
12,068

 
79

 
15,450

Interest (expense) income, net
(8,898
)
 
1,408

 
(1,888
)
 

 
(9,378
)
Foreign exchange loss
(538
)
 
(126
)
 
(241
)
 

 
(905
)
Equity in subsidiaries income
13,992

 
6,139

 

 
(20,131
)
 

Income before provision for income taxes
2,432

 
12,848

 
9,939

 
(20,052
)
 
5,167

Provision for income taxes
(328
)
 
(23
)
 
(2,712
)
 

 
(3,063
)
Net income
$
2,104

 
$
12,825

 
$
7,227

 
$
(20,052
)
 
$
2,104

Comprehensive income
$
2,563

 
$
12,975

 
$
13,696

 
$
(20,052
)
 
$
9,182




21


Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive (Loss) Income (Unaudited)
For the nine months ended September 30, 2014
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
139,352

 
$
299,501

 
$
(26,888
)
 
$
411,965

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(1,095
)
 
95,050

 
182,029

 
(27,030
)
 
248,954

    Selling
700

 
15,530

 
39,132

 

 
55,362

    General and administrative
6,764

 
5,966

 
30,607

 

 
43,337

    Research and development
779

 
3,453

 
1,667

 

 
5,899

    Restructuring and impairment
129

 
868

 
14,715

 

 
15,712

 
7,277

 
120,867

 
268,150

 
(27,030
)
 
369,264

(Loss) income from operations
(7,277
)
 
18,485

 
31,351

 
142

 
42,701

Interest (expense) income, net
(25,546
)
 
4,132

 
(5,571
)
 

 
(26,985
)
Foreign exchange loss
(549
)
 
(115
)
 
(154
)
 

 
(818
)
Equity in subsidiaries income
15,558

 
(8,897
)
 

 
(6,661
)
 

(Loss) income before provision for income taxes
(17,814
)
 
13,605

 
25,626

 
(6,519
)
 
14,898

Provision for income taxes
(728
)
 
(100
)
 
(32,612
)
 

 
(33,440
)
Net loss
$
(18,542
)
 
$
13,505

 
$
(6,986
)
 
$
(6,519
)
 
$
(18,542
)
Comprehensive loss
$
(19,138
)
 
$
13,087

 
$
(26,912
)
 
$
(6,519
)
 
$
(39,482
)

Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive (Loss) Income-(Unaudited)
For the nine months ended September 30, 2013
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
138,303

 
$
311,319

 
$
(36,451
)
 
$
413,171

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(1,270
)
 
94,341

 
196,087

 
(36,530
)
 
252,628

    Selling

 
16,939

 
38,110

 

 
55,049

    General and administrative
6,766

 
4,072

 
34,580

 

 
45,418

    Research and development

 
4,224

 
1,710

 

 
5,934

    Restructuring and impairment
61

 
831

 
7,562

 

 
8,454

 
5,557

 
120,407

 
278,049

 
(36,530
)
 
367,483

(Loss) income from operations
(5,557
)
 
17,896

 
33,270

 
79

 
45,688

Interest (expense) income, net
(23,715
)
 
4,219

 
(12,201
)
 

 
(31,697
)
Foreign exchange loss
(442
)
 
(130
)
 
(530
)
 

 
(1,102
)
Equity in subsidiaries income
33,970

 
9,124

 

 
(43,094
)
 

Loss on extinguishment of debt
(3,123
)
 

 

 

 
(3,123
)
Dividend income

 
1,555

 

 
(1,555
)
 

Income before provision for income taxes
1,133

 
32,664

 
20,539

 
(44,570
)
 
9,766

(Provision) benefit for income taxes
(422
)
 
45

 
(8,678
)
 

 
(9,055
)
Net income
$
711

 
$
32,709

 
$
11,861

 
$
(44,570
)
 
$
711

Comprehensive income
$
(632
)
 
$
32,815

 
$
15,052

 
$
(44,570
)
 
$
2,665




22




Xerium Technologies, Inc.
Consolidating Statement of Cash Flows-(Unaudited)
For the nine months ended September 30, 2014
(Dollars in thousands) 
 
Parent    
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
 Company 
Operating activities
 
 
 
 
 
 
 
 
 
Net (loss) income
$
(18,542
)
 
$
13,505

 
$
(6,986
)
 
$
(6,519
)
 
$
(18,542
)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
 
Stock-based compensation
1,673

 

 
185

 

 
1,858

Depreciation
809

 
5,415

 
18,726

 

 
24,950

Amortization of intangibles

 
1,151

 
79

 

 
1,230

Deferred financing cost amortization
2,394

 

 
15

 

 
2,409

Foreign exchange gain on revaluation of debt
(340
)
 

 

 

 
(340
)
Deferred tax expense
656

 

 
853

 

 
1,509

Asset impairment

 

 
277

 

 
277

Loss (gain) on disposition of property and equipment

 
27

 
(31
)
 

 
(4
)
Provision for doubtful accounts

 
166

 
118

 

 
284

Undistributed equity in earnings of subsidiaries
(15,558
)
 
8,897

 

 
6,661

 

Change in assets and liabilities which provided (used) cash:
 
 
 
 
 
 
 
 


Accounts receivable
(10
)
 
(705
)
 
(4,332
)
 

 
(5,047
)
Inventories

 
600

 
(8,355
)
 
(142
)
 
(7,897
)
Prepaid expenses
365

 
(802
)
 
557

 

 
120

Other current assets
514

 
(517
)
 
1,226

 

 
1,223

Accounts payable and accrued expenses
2,894

 
485

 
208

 

 
3,587

Deferred and other long-term liabilities
(585
)
 
(39
)
 
(3,676
)
 

 
(4,300
)
Intercompany loans
(18,899
)
 
553

 
18,346

 

 

Net cash (used in) provided by operating activities
(44,629
)
 
28,736

 
17,210

 

 
1,317

Investing activities
 
 
 
 
 
 
 
 
 
Capital expenditures, gross
(10,229
)
 
(4,089
)
 
(19,348
)
 

 
(33,666
)
Intercompany property and equipment transfers, net
13,204

 
(6
)
 
(13,198
)
 

 

Proceeds from disposals of property and equipment

 
36

 
127

 

 
163

Other investing activities
(26,100
)
 
25,600

 
500

 

 

Net cash (used in) provided by investing activities
(23,125
)
 
21,541

 
(31,919
)
 

 
(33,503
)
Financing activities
 
 
 
 
 
 
 
 

Proceeds from borrowings
67,943

 

 
5,636

 

 
73,579

Principal payments on debt
(39,449
)
 

 
(5,385
)
 

 
(44,834
)
Payment of obligations under capital leases
(383
)
 
(251
)
 

 

 
(634
)
Payment of financing fees
(623
)
 

 
(775
)
 

 
(1,398
)
Intercompany loans
37,885

 
(50,026
)
 
12,141

 

 

Net cash provided by (used in) financing activities
65,373

 
(50,277
)
 
11,617

 

 
26,713

Effect of exchange rate changes on cash flows

 
1

 
(431
)
 

 
(430
)
Net (decrease) increase in cash
(2,381
)
 
1

 
(3,523
)
 

 
(5,903
)
Cash and cash equivalents at beginning of period
4,120

 
(10
)
 
21,606

 

 
25,716

Cash and cash equivalents at end of period
$
1,739

 
$
(9
)
 
$
18,083

 
$

 
$
19,813


23



Xerium Technologies, Inc.
Consolidating Statement of Cash Flows (Unaudited)
For the nine months ended September 30, 2013
(Dollars in Thousands)
 
Parent    
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
 Company 
Operating activities
 
 
 
 
 
 
 
 
 
Net income
$
711

 
$
32,709

 
$
11,861

 
$
(44,570
)
 
$
711

Adjustments to reconcile net income to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
 
Stock-based compensation
1,120

 

 
21

 

 
1,141

Depreciation
94

 
5,599

 
20,358

 

 
26,051

Amortization of intangibles

 
1,298

 
70

 

 
1,368

Deferred financing cost amortization
(1,466
)
 

 
3,759

 

 
2,293

Foreign exchange (gain) loss on revaluation of debt
(410
)
 
(45
)
 
2,081

 

 
1,626

Deferred taxes
291

 

 
1,048

 

 
1,339

Asset impairment
17

 
341

 
720

 

 
1,078

Loss on disposition of property and equipment
132

 
17

 
5

 

 
154

Loss on extinguishment of debt
3,123

 

 

 

 
3,123

Provision for doubtful accounts

 
155

 
388

 

 
543

Undistributed equity in earnings of subsidiaries
(33,970
)
 
(9,124
)
 

 
43,094

 

Change in assets and liabilities which provided (used) cash:
 
 
 
 
 
 
 
 


Accounts receivable
25

 
(3,151
)
 
(7,473
)
 

 
(10,599
)
Inventories

 
(1,057
)
 
(4,059
)
 
(79
)
 
(5,195
)
Prepaid expenses
(194
)
 
(23
)
 
1,931

 

 
1,714

Other current assets
(151
)
 
47

 
(922
)
 

 
(1,026
)
Accounts payable and accrued expenses
8,667

 
55

 
(2,841
)
 
1,555

 
7,436

Deferred and other long-term liabilities
93

 
153

 
(1,572
)
 

 
(1,326
)
Intercompany loans
1,834

 
(2,635
)
 
801

 

 

Net cash (used in) provided by operating activities
(20,084
)
 
24,339

 
26,176

 

 
30,431

Investing activities
 
 
 
 
 
 
 
 
 
Capital expenditures, gross
(4,274
)
 
(2,166
)
 
(9,122
)
 

 
(15,562
)
Intercompany property and equipment transfers, net
3

 
88

 
(91
)
 

 

Proceeds from disposals of property and equipment

 
4

 
2,231

 

 
2,235

Net cash used in investing activities
(4,271
)
 
(2,074
)
 
(6,982
)
 

 
(13,327
)
Financing activities
 
 
 
 
 
 
 
 

Proceeds from borrowings
199,000

 

 

 

 
199,000

Principal payments on debt
(105,057
)
 

 
(93,791
)
 

 
(198,848
)
Payment of deferred financing fees
(3,030
)
 

 

 

 
(3,030
)
Intercompany loans
(59,415
)
 
(22,310
)
 
81,725

 

 

Net cash provided by (used in) financing activities
31,498

 
(22,310
)
 
(12,066
)
 

 
(2,878
)
Effect of exchange rate changes on cash flows

 

 
(221
)
 

 
(221
)
Net increase (decrease) in cash
7,143

 
(45
)
 
6,907

 

 
14,005

Cash and cash equivalents at beginning of period
6,471

 
36

 
28,270

 

 
34,777

Cash and cash equivalents at end of period
$
13,614

 
$
(9
)
 
$
35,177

 
$

 
$
48,782



24


ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to the safe harbor created by that Act. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. Undue reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of activity, performance, or achievements. Factors that could materially affect our actual results, levels of activity, performance or achievements include the following items:

our strategy to lower our costs in response to market changes in the paper industry by reorganizing and restructuring our operations will require us to incur significantly higher costs in the short-term and may not provide the cost reductions and results we anticipate;
we are subject to execution risk related to the startup of our proposed new facilities in China and Turkey;
we are subject to the risk of a weaker global economy that influences the paper industry as well as local economic conditions in the areas around the world where we conduct business;
structural shifts in the demand for paper, for instance the shift away from newsprint, printing and writing paper in favor of digital media, may adversely impact customers' demand for our products and services and consequently our financial results;
our strategies and plans, including, but not limited to, those relating to developing and successfully marketing new products, expanding our customer base by diversifying our products, enhancing our operational efficiencies and reducing costs, may not result in the anticipated benefits;
our financial results could be adversely affected by fluctuations in interest rates and currency exchange rates;
our manufacturing facilities may be required to quickly increase or decrease production capacity, which could negatively affect our production, customer order lead time, product quality, labor relations or gross margin;
we may not be successful in developing and marketing new technologies or in competing against new technologies developed by competitors;
variations in demand for our products, including our new products, could negatively affect our net sales and profitability;
we are subject to fluctuations in the price of our component supply costs;
due to our high degree of leverage and significant debt service obligations, we need to generate substantial operating cash flow to fund growth and unexpected cash needs;
we are subject to the risk of terrorist attacks or an outbreak or escalation of any insurrection or armed conflict involving the United States or any other country in which we conduct business, or any other domestic or international calamity, including natural disasters;
we are subject to the impact of changes in the policies, laws, regulations and practices of the United States and any foreign country in which we operate or conduct business, including changes regarding taxes and the repatriation of earnings; and
anti-takeover provisions could make it more difficult for a third-party to acquire us.

Other factors that could materially affect our actual results, levels of activity, performance or achievements can be found in our “Risk Factors” section in our Annual Report on Form 10-K for the year ended December 31, 2013, filed with the SEC on March 4, 2014. If any of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we project. Any forward-looking statement in this Quarterly Report on Form 10-Q reflects our current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to our operations, results of operations, growth strategy, and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as required by law.
All references in this Quarterly Report to “Xerium”, “the Company”, “we”, “our” and “us” means Xerium Technologies, Inc. and its subsidiaries.


25


Company Overview
We are a leading global manufacturer and supplier of two types of consumable products used primarily in the production of paper—clothing and roll covers. Our operations are strategically located in the major paper-producing regions of North America, Europe, South America and Asia-Pacific. Our products play key roles in the formation and processing of paper along the length of a paper-making machine. Paper producers rely on our products and services to help improve the quality of their paper, differentiate their paper products, operate their paper-making machines more efficiently and reduce production costs.
We operate in two principal business segments: clothing and roll covers. In our clothing segment, we manufacture and sell highly engineered synthetic textile belts that transport paper as it is processed in a paper-making machine. Clothing plays a significant role in the forming, pressing and drying stages of paper production. Because paper-making processes and machine specifications vary widely, the clothing size, form, material and function is custom engineered to fit each individual paper-making machine and process. For the nine months ended September 30, 2014, our clothing segment represented 64% of our net sales.
Our roll cover products provide a surface with the mechanical properties necessary to process the paper sheet in a cost-effective manner that delivers the sheet qualities desired by each paper producer. We tailor our roll covers to individual paper-making machines and processes, using different materials, treatments and finishings. In addition to manufacturing and selling new roll covers, we also provide refurbishment services for previously installed roll covers and we manufacture new and rebuilt spreader rolls. We also provide various related products and services to our customers, both directly and through third party providers, as a growing part of our overall product offering through our roll covers sales channels. For the nine months ended September 30, 2014, our roll cover segment represented 36% of our net sales.
Industry Trends and Outlook
      
Historically, demand for our products has been driven primarily by the volume (tonnage) of paper produced on a worldwide basis, which in turn is affected by global economic conditions. Since 2000, paper producers have taken actions that seek to structurally improve the balance between the supply of, and demand for, paper in response to the industry's highly cyclical swings in profitability driven by the oversupply of paper during periods when paper producers have more aggregate capacity than the market requires. As part of these efforts, they have permanently shut down many paper-making machines or entire manufacturing facilities.

Beginning about the same time the paper industry began to address the structural balance between the supply and demand for paper, the widespread adoption of e-commerce and digitalization of traditionally printed material has resulted in a prolonged decline in newsprint and printing and writing grades of paper. This longer term decline has been partially offset by increases in the production of packaging grades, both as a consequence of globalization of manufacturing and as a result of the increase of tissue/personal care products which have increased as global GDP has risen, particularly in the developing world. In 2010 and 2011, global paper and board production began to recover from the economic recession and show growth, particularly in developing countries. As international shipments of manufactured goods increased, containerboard production recovered particularly strongly, contributing over 50% of the total global improvement. The paper and board production recovery, however, stalled in the second half of 2011 and remained weak throughout 2012 and 2013. In 2014, we still expect that global paper and board manufacturers' operating rates will remain near their 2013 levels, while industry forecasters predict the growth of global paper production from 2014 to 2015 to be between approximately 2% and 3% per annum. Generally, and over time, we expect growth in paper production to be greater in Asia-Pacific and South America than in the more mature North American and European regions, where demand has declined.

Despite projected growth, many paper producers continue to experience low levels of profitability. Any anticipated global paper production growth would be moderated by further consolidation among papermakers, reduction in the number of paper producers, and shutdowns of paper-making machines or facilities, which we believe will continue, particularly in Europe and North America, until there is a better balance between supply and demand for paper and the profit levels of paper producers improve.

Also affecting machine curtailments are structural productivity gains from new paper machine designs that have fewer rolls and from improved products that we and our competitors supply, which enable paper producers to manufacture more paper with fewer machines. In particular, market recognition of the extended life of our roll cover products has, and will likely continue to, negatively impact demand for these products and their volume potential. Additionally, we are seeing a trend that paper producers are placing an increasing emphasis on maintenance cost reduction and, as a result, are extending the life of roll covers through additional maintenance cycles before replacing them. However, we believe volume declines would be at least partially offset by our introduction of new products with the extended life qualities that our customers desire and increasing market share of proprietary products such as our SmartRoll™.

26



In response to this, we expect to continue to focus our research and development efforts on new products that deliver increased value to our customers and for which they will pay increased prices. In addition, we intend to continue to enhance and deploy our value added selling approach as part of our strategy to differentiate our products, while at the same time we remain focused on cost reduction and efficiency programs.

The negative paper industry trends described above are likely to continue. We believe that the paper industry will continue to experience an increased emphasis on cost reduction and continued paper-machine shutdown activity. These underlying industry dynamics could negatively impact our business, results of operations and financial condition and are the key drivers behind our strategy to reduce our cost structure, align our geographic footprint with anticipated growth in the South America and Asia-Pacific regions and grow our non-paper business revenue streams.
Net Sales and Expenses
The following factors primarily drive net sales in both our clothing and roll covers segments:
the volume (tonnage) of worldwide paper production;
our ability to introduce new products that our customers value and will pay for;
advances in technology of our products, which can provide value to our customers by improving the efficiency of paper-making machines and reduce their manufacturing costs;
growth in developing markets, particularly in Asia;
the mix of paper grades being produced;
our ability to enter and expand our business in non-paper products; and
the impact of currency fluctuations.
  
  Net sales in our roll covers segment include our mechanical services business. We have expanded this business in response to demand from paper producers that we perform work on the internal mechanisms of their rolls while we refurbish or replace a roll cover. In our clothing segment, we conduct a small portion of our business pursuant to consignment arrangements; for these, we do not recognize a sale of a product to a customer until the customer places the product into use, which typically occurs some period after we ship the product to the customer or to a warehouse location near the customer’s facility. As part of the consignment agreement, we deliver the goods to a location designated by the customer. In addition, we agree to a “sunset” date with the customer, which represents the date by which the customer must accept all risks and responsibilities of ownership of the product and payment terms begin. For consignment sales, we recognize revenue on the earlier of the actual product installation date or the “sunset” date.
Our operating cost levels are impacted by total sales volume, raw material costs, the impact of inflation, foreign currency fluctuations and the success of our cost reduction programs.
The level of our cost of products sold is primarily attributable to labor costs, raw material costs, product shipping costs, plant utilization and depreciation, with labor costs constituting the largest component. We invest in facilities and equipment that enable innovative product development and improve production efficiency and costs. Recent examples of capital spending for such purposes include faster weaving looms and seaming machines with accurate electronic controls, automated compound mixing equipment and computer-controlled lathes and mills.
The level of research and development spending is driven by market demand for technology enhancements, including both specific customer needs and general market requirements, as well as by our own analysis of applied technology opportunities. With the exception of purchases of equipment and similar capital items used in our research and development activities, all research and development is expensed as incurred. Research and development expenses were $1.9 million and $1.8 million for the three months ended September 30, 2014 and 2013, respectively.

Foreign Exchange
We have a geographically diverse customer base. In the nine months ended September 30, 2014, we generated approximately 38% of our net sales in North America, 34% in Europe, 19% in Asia-Pacific and 9% in South America.
A substantial portion of our net sales is denominated in Euros or other currencies. As a result, changes in the relative values of U.S. Dollars, Euros and other currencies affect our reported levels of net sales and profitability as the results are translated into U.S. Dollars for reporting purposes. In particular, decreases in the value of the U.S. Dollar relative to the

27


value of the Euro and these other currencies positively impact our levels of revenue and profitability because the translation of a certain number of Euros or units of such other currencies into U.S. Dollars for financial reporting purposes will represent more U.S. Dollars than it would have prior to the relative decrease in the value of the U.S. Dollar. Conversely, a decline in the value of the Euro will result in a lower number of U.S. Dollars for financial reporting purposes.
For certain transactions, our net sales are denominated in U.S. Dollars, but all or a substantial portion of the associated costs are denominated in a different currency. As a result, changes in the relative values of U.S. Dollars, Euros and other currencies can affect the level of the profitability of these transactions. The largest proportion of such transactions consists of transactions in which the net sales are denominated in or indexed to the U.S. Dollar and all or a substantial portion of the associated costs are denominated in Brazilian Reals or other currencies.
During the nine months ended September 30, 2014, we conducted business in nine foreign currencies. The following table provides the average exchange rate for the nine months ended September 30, 2014 and the nine months ended September 30, 2013 of the U.S. Dollar against each of the four foreign currencies in which we conduct the largest portion of our operations.
 
Currency
  
Nine months ended September 30, 2014
  
Nine months ended September 30, 2013
Euro
  
$1.36 = 1 Euro
  
$1.32 = 1 Euro
Brazilian Real
  
$0.44 = 1 Brazilian Real
  
$0.47 = 1 Brazilian Real
Canadian Dollar
  
$0.91 = 1 Canadian Dollar
  
$0.98 = 1 Canadian Dollar
Australian Dollar
  
$0.92 = 1 Australian Dollar
  
$0.98= 1 Australian Dollar
In the nine months ended September 30, 2014, we conducted approximately 35% of our operations in Euros, approximately 10% in the Australian Dollar, approximately 8% in the Brazilian Real (although a significant portion of Brazil net sales are in U.S. Dollars) and approximately 5% in the Canadian Dollar.
To mitigate the risk of transactions in which a sale is made in one currency and associated costs are denominated in a different currency, we may utilize forward currency contracts in certain circumstances to lock in exchange rates with the objective that the gain or loss on the forward contracts will approximate the loss or gain that results from the transaction or transactions being hedged. We determine whether to enter into hedging arrangements based upon the size of the underlying transaction or transactions, an assessment of the risk of adverse movements in the applicable currencies and the availability of a cost effective hedge strategy. To the extent we do not engage in hedging or such hedging is not effective, changes in the relative value of currencies can affect our profitability.

Domestic and Foreign Operating Results:
The following is an analysis of our domestic and foreign operations during the three and nine months ended September 30, 2014 and September 30, 2013 and a discussion of the results of operations during those periods (in thousands):
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Domestic income from operations
$
5,067

 
$
3,303

 
$
11,208

 
$
12,339

Foreign income from operations
12,724

 
12,147

 
31,493

 
33,349

Total income from operations
$
17,791

 
$
15,450

 
$
42,701

 
$
45,688

During the three and nine months ended September 30, 2014, domestic income from operations was lower than foreign income from operations primarily due to product mix, market differences and various unallocated corporate expenses. Foreign un-remitted earnings generated in years prior to 2013 will remain indefinitely reinvested, except for a portion of Brazil and Mexico, for which U.S. income taxes and foreign withholding taxes have been provided. However, the earnings generated by foreign subsidiaries in 2013 and 2014 will be remitted to the parent company at some point in the future. U.S. income taxes and foreign withholding taxes have been provided related to those foreign earnings.
Cost Reduction Programs

28


An important part of our strategy is to seek to reduce our overall costs and improve our competitiveness. As a part of this effort, we engage in cost reduction programs, which are designed to improve the cost structure of our global operations in response to changing market conditions. These cost reduction programs include headcount reductions throughout the world as well as plant closures that are intended to rationalize production among our facilities to better enable us to match our cost structure with customer demand. Cost savings have been realized and are expected to be realized in labor costs and other production overhead, other components of costs of products sold, general and administrative expenses and facility costs. The majority of cost savings begin at the time of the headcount reductions and plant closure with remaining cost savings recognized over subsequent periods. Cost savings from headcount reductions have not been and are not expected to be offset by related increases in other expenses. Cost savings related to plant closures have been and are expected to be partially offset by additional costs incurred in the facilities that assumed the operations of the closed facility.
 
For the nine months ended September 30, 2014, we incurred restructuring expenses of $15.7 million. These charges were related to $4.2 million in headcount reductions, $3.7 million of charges related to the closure of the Heidenheim rolls facility, $3.0 million in severance and other charges due to the final negotiated severance package at the Joao Pessoa, Brazil clothing facility, a $1.6 million charge in Italy to terminate a sales agency contract, $1.4 million in severance charges relating to the closure of the Argentina press felt facility, $0.7 million of charges to move certain equipment from the closed France rolls facility to China and other locations in Europe, $0.3 million of costs associated with liquidating the Vietnam facility, and $0.8 million in severance and facility charges relating to the Spain closure. For the nine months ended September 30, 2013, we incurred restructuring expenses of $8.5 million. These included charges relating to headcount reductions, the closure of two clothing facilities in Spain and Argentina and the closure of a roll cover facility in Charlotte, NC.

Results of Operations

The table that follows sets forth for the periods presented certain consolidated operating results.
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
 
(in thousands)
 
(in thousands)
Net sales
$
138,858

 
$
135,042

 
$
411,965

 
$
413,171

Costs and expenses:
 
 
 
 
 
 
 
Cost of products sold
83,364

 
81,656

 
248,954

 
252,628

Selling
18,195

 
17,779

 
55,362

 
55,049

General and administrative
14,133

 
15,278

 
43,337

 
45,418

Research and development
1,909

 
1,845

 
5,899

 
5,934

Restructuring
3,466

 
3,034

 
15,712

 
8,454

 
121,067

 
119,592

 
369,264

 
367,483

Income from operations
17,791

 
15,450

 
42,701

 
45,688

Interest expense, net
(9,412
)
 
(9,378
)
 
(26,985
)
 
(31,697
)
Loss on extinguishment of debt

 

 

 
(3,123
)
Foreign exchange gain (loss)
367

 
(905
)
 
(818
)
 
(1,102
)
Income before provision for income taxes
8,746

 
5,167

 
14,898

 
9,766

Provision for income taxes
(29,218
)
 
(3,063
)
 
(33,440
)
 
(9,055
)
Net (loss) income
$
(20,472
)
 
$
2,104

 
$
(18,542
)
 
$
711

Comprehensive (loss) income
$
(41,003
)
 
$
9,182

 
$
(39,482
)
 
$
2,665

Three Months Ended September 30, 2014 Compared to the Three Months Ended September 30, 2013
Net Sales. Net sales for the three months ended September 30, 2014 increased by $3.9 million, or 2.9%, to $138.9 million from $135.0 million for the three months ended September 30, 2013. For the three months ended September 30, 2014, approximately 62% of our net sales were in our clothing segment and approximately 38% were in our roll covers segment.
In our clothing segment, net sales for the three months ended September 30, 2014 decreased $(1.9) million to $86.1 million from $88.0 million for the three months ended September 30, 2013. Excluding unfavorable currency effect of $(0.6) million, the remaining decrease of $(1.3) million in net sales was primarily due to (1) a decrease in sales volume in Europe of $(1.7) million, resulting from a sluggish economy continuing into the third quarter of 2014; (2) a decrease in sales volume in North America of ($1.4) million due to timing of production; and (3) a decrease in sales volume in Asia of $(0.2) million. These

29


decreases were partially offset by a $1.3 million decrease in returns and allowances and an increase in sales volume of $0.8 million in South America.
In our roll covers segment, net sales for the three months ended September 30, 2014 increased by $5.7 million or 12.1%, to $52.8 million from $47.1 million for the three months ended September 30, 2013. Excluding unfavorable currency effects of $(0.2) million, the remaining increase of $5.9 million was primarily due to (1) higher net sales of $5.5 million in North America, primarily as a result of increased roll cover net sales of $3.3 million and increased mechanical service sales of $2.2 million; (2) higher net sales of $0.8 million in Asia; and (3) higher net sales of $0.3 million in South America. These increases were partially offset by net sales declines in Europe of ($0.7) million resulting from a sluggish economy continuing into the third quarter of 2014.
Cost of Products Sold. Cost of products sold for the three months ended September 30, 2014 increased by $1.7 million, or 2.1%, to $83.4 million from $81.7 million for the three months ended September 30, 2013.
In our clothing segment, cost of products sold decreased $(1.3) million in the current quarter compared to the third quarter of 2013, as a result of decreased sales volume and lower cost of products sold as a percentage of sales and favorable currency effects of $0.4 million. Cost of products sold as a percentage of net sales decreased by (0.3)% to 59.1% in the three months ended September 30, 2014 from 59.4% in the three months ended September 30, 2013. This decrease was primarily due to reduced costs as a result of restructuring and cost reduction savings and operational efficiencies, partially offset by inflationary wage increases and sales of products with lower gross margins.
In our roll covers segment, cost of products sold increased $3.1 million in the current quarter compared to the third quarter of 2013, primarily as a result of increased sales volume, partially offset by lower cost of products sold, as a percentage of net sales. Cost of products sold as a percentage of net sales decreased by (1.0)% to 61.5% for the three months ended September 30, 2014 from 62.5% for the three months ended September 30, 2013. This decrease was primarily due to restructuring and cost reduction savings and operational efficiencies, partially offset by increased cost of goods sold as a result of higher sales of products and services with lower gross margins. These decreases were partially offset by favorable currency effects of $0.1 million.
Selling Expenses. For the three months ended September 30, 2014, selling expenses increased by $0.4 million, or 2.2%, to $18.2 million from $17.8 million for the three months ended September 30, 2013. This increase was primarily driven by increased net sales volume and a gain realized in 2013 related to the sale of the selling department vehicle fleet of $0.2 million, which did not occur in 2014. These increases were partially offset by favorable currency effects of $0.2 million.

General and Administrative Expenses. For the three months ended September 30, 2014, general and administrative expenses decreased by $(1.2) million, or (7.8)%, to $14.1 million from $15.3 million for the three months ended September 30, 2013, primarily as a result of headcount reductions, restructuring savings and other cost reduction efforts and decreased management incentive compensation of $0.7 million, partially offset by inflationary increases in salaries and China and Turkey startup costs.
Restructuring Expenses. For the three months ended September 30, 2014, we incurred restructuring expenses of $3.5 million. These included charges relating to (1) $0.3 million of impairment charges, $0.7 million in final severance charges and $0.4 million in facility and other period charges due to the final approval of a plan to shut down the Company's Joao Pessoa, Brazil clothing facility; (2) $0.8 million of charges relating to the Company's Heidenheim closure; (3) $0.8 million of severance charges for headcount reductions; and (4) $0.5 million in charges relating to ongoing facility costs for Spain and France closures.
Interest Expense, Net. Net interest expense for the three months ended September 30, 2014 and 2013 was $9.4 million Increases were primarily due to increased average borrowings, and were offset by capitalized interest related to certain equipment construction projects in the third quarter of 2014 and lower average interest rates during the third quarter of 2014 versus the third quarter of 2013.
Provision for Income Taxes. For the three months ended September 30, 2014 and 2013, the provision for income taxes was $29.2 million and $3.1 million, respectively. The increase in income tax expense was primarily attributable to the settlement of a tax assessment in Brazil by entering a tax amnesty program and making a lump sum payment which increased income taxes by $25.0 million, as well as the geographic mix of earnings in the third quarter of 2014 as compared to the third quarter of 2013. Generally, in the absence of a large settlement payment such as the one made in Brazil during the three months ended September 30, 2014, our provision for income taxes is primarily impacted by the income we earn in tax paying jurisdictions relative to the income we earn in non-tax paying jurisdictions. The majority of income recognized for purposes of computing our effective tax rate is earned in countries where the statutory income tax rates range from 15% to 39%. However, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than

30


the statutory tax rate in these jurisdictions. We generate losses in certain jurisdictions for which we realize no tax benefit as the deferred tax assets in these jurisdictions (including net operating losses) are fully reserved in our valuation allowance. For this reason, we recognize minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States, the United Kingdom and Australia. Due to these reserves, the geographic mix of our pre-tax earnings has a direct correlation with how high or low our annual effective tax rate is relative to consolidated earnings.
Nine Months Ended September 30, 2014 Compared to the Nine Months Ended September 30, 2013
Net Sales. Net sales for the nine months ended September 30, 2014 decreased by $(1.2) million, or (0.3)%, to $412.0 million from $413.2 million for the nine months ended September 30, 2013. For the nine months ended September 30, 2014, approximately 64% of our net sales were in our clothing segment and approximately 36% were in our roll covers segment.
In our clothing segment, net sales for the nine months ended September 30, 2014 decreased by $(2.7) million, or (1.0)%, to $264.6 million from $267.3 million for the nine months ended September 30, 2013, primarily due to (1) lower net sales of ($3.7) million in Europe, resulting from a sluggish economy; (2) a decrease in net sales of ($1.8) million in North America, primarily due to timing of production; and (3) a ($0.5) million decline in net sales in Asia. These decreases were partially offset by increased net sales of $1.9 million in South America and a $1.5 million decrease in returns and allowances in 2014.
In our roll covers segment, net sales for the nine months ended September 30, 2014 increased by $1.6 million or 1.1%, to $147.4 million from $145.8 million for the nine months ended September 30, 2013. When adjusted for favorable currency effects of $0.2 million, net sales increased $1.4 million, or 0.9%, primarily due to (1) increased net sales of $4.6 million in North America, primarily as a result of increased mechanical service sales of $3.6 million and increased roll cover net sales of $1.0 million; (2) a $0.5 million increase in net sales in South America; and (3) a $0.4 million increase in net sales in Asia. These increases were partially offset by net sales declines in Europe of ($4.3) million resulting from a sluggish economy.
Cost of Products Sold. Cost of products sold for the nine months ended September 30, 2014 decreased by $(3.6) million, or (1.4)%, to $249.0 million from $252.6 million for the nine months ended September 30, 2013.
In our clothing segment, cost of products sold decreased $(6.9) million to $155.2 million in the nine months ended September 30, 2014 compared to $162.1 million in the nine months ended September 30, 2013 as a result of favorable currency effects of $1.6 million, lower sales volume and decreased cost of products sold as a percentage of sales. Cost of products sold, as a percentage of net sales decreased by (1.9)% to 58.7% in the nine months ended September 30, 2014 from 60.6% in the nine months ended September 30, 2013. This decrease was primarily due to restructuring and cost reduction savings, operational efficiencies and favorable absorption in North America and South America due to increased production levels.
In our roll covers segment, cost of products sold increased $3.1 million in the nine months ended September 30, 2014 compared to the nine months ended September 30, 2013, primarily due to increased sales volume and unfavorable currency effects of $0.3 million. Cost of products sold as a percentage of net sales increased by 2.5% to 63.6% for the nine months ended September 30, 2014 from 62.1% for the nine months ended September 30, 2013. This increase was primarily due to unfavorable sales mix as a result of higher sales of products and services with lower gross margins.
Selling Expenses. For the nine months ended September 30, 2014, selling expenses increased by $0.4 million, or 0.7%, to $55.4 million from $55.0 million for the nine months ended September 30, 2013. The increase was primarily a result of a gain realized in 2013 related to the sale of the selling department vehicle fleet of $0.6 million, which did not occur in 2014, partially offset by a decrease in sales volume in 2014.

General and Administrative Expenses. For the nine months ended September 30, 2014, general and administrative expenses decreased by $(2.1) million, or (4.6)%, to $43.3 million from $45.4 million for the nine months ended September 30, 2013, primarily as a result of our cost reduction initiatives, a decrease in management incentive compensation of $(2.0) million and a decrease in 2014 related to the impairment of a vacant facility of $0.6 million in 2013. Partially offsetting these decreases was an increase in 2014 related to a $0.7 million gain realized in 2013 related to an insurance recovery from a plant fire, which did not occur in 2014 and $1.0 million in plant start up costs incurred in 2014.
Restructuring Expenses. For the nine months ended September 30, 2014, we incurred restructuring expenses of $15.7 million. These charges were related to $4.2 million in headcount reductions, $3.7 million of charges related to the closure of the Heidenheim rolls facility, $3.0 million in severance and other charges due to the final negotiated severance package at the Joao Pessoa, Brazil clothing facility, a $1.6 million charge in Italy to terminate a sales agency contract, $1.4 million in severance charges relating to the closure of the Argentina press felt facility, $0.7 million of charges to move certain equipment from the closed France rolls facility to China and other locations in Europe, $0.3 million of costs associated with liquidating the Vietnam facility, and $0.8 million in severance and facility charges relating to the Spain closure. For the nine months ended

31


September 30, 2013, we incurred restructuring expenses of $8.5 million. These included charges relating to headcount reductions, the closure of two clothing facilities in Spain and Argentina and the closure of a roll cover facility in Charlotte, NC.
Interest Expense, Net. Net interest expense for the nine months ended September 30, 2014 decreased by $4.7 million, or 14.8%, to $27.0 million from $31.7 million for the nine months ended September 30, 2013. The decrease was primarily due to increased interest expenses in 2013 related to our debt refinancing, capitalized interest related to certain equipment construction projects in 2014 and lower average interest rates during 2014 versus 2013.
Provision for Income Taxes. For the nine months ended September 30, 2014 and 2013, the provision for income taxes was $33.4 million and $9.1 million, respectively. The increase in income tax expense was primarily attributable to the settlement of a tax assessment in Brazil by entering a tax amnesty program and making a lump sum payment which increased income taxes by $25.0 million, as well as the geographic mix of earnings in the nine months ended September 30, 2014 as compared to the nine months ended September 30, 2013. Generally, in the absence of a large settlement payment such as the one made in Brazil during the nine months ended September 30, 2014, our provision for income taxes is primarily impacted by the income we earn in tax paying jurisdictions relative to the income we earn in non-tax paying jurisdictions. The majority of income recognized for purposes of computing our effective tax rate is earned in countries where the statutory income tax rates range from 15% to 39%. However, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. We generate losses in certain jurisdictions for which we realize no tax benefit as the deferred tax assets in these jurisdictions (including net operating losses) are fully reserved in our valuation allowance. For this reason, we recognize minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States, the United Kingdom and Australia. Due to these reserves, the geographic mix of our pre-tax earnings has a direct correlation with how high or low our annual effective tax rate is relative to consolidated earnings.

Liquidity and Capital Resources
Our principal liquidity requirements are for debt service, restructuring payments, working capital and capital expenditures. We plan to use cash on hand, cash generated by operations and, should it become necessary, access to our revolving credit facility, as our primary sources of liquidity. Our operations are highly dependent upon the paper production industry and the degree to which the paper industry is affected by global economic conditions and the availability of credit. Demand for our products could decline if paper manufacturers are unable to obtain required financing or if economic conditions cause additional mill closures. In addition, the impact of the most recent global economic recession and the continued lack of availability of credit may affect our customers’ ability to pay their debts.
As stated in Note 4, "Income Taxes," to our Unaudited Condensed Consolidated Financial Statements, we chose to participate in an amnesty program offered by the Federal Revenue Department of the Ministry of Finance of Brazil ("FRD"). The amnesty program offered significant reductions on the penalties and interest that have been assessed against the Company. By paying a lump sum amount of $25.0 million, we received a reduction of 100% of the penalties assessed and a 45% reduction of interest accrued on our tax assessment relating to tax years 2006 through 2010. Because tax amnesty and voluntary disclosure programs were open for tax years beyond the time period of our particular assessment, we also included in our payment to the Brazilian government amounts relating to tax years 2011 through 2013, which corresponded to the same tax deductions under review in our assessment for tax years 2006 through 2010. As previously discussed in Note 3 to the consolidated financial statements, we borrowed an additional $30.0 million under our Incremental Facility to fund this tax settlement payment, by entering into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”) on August 18, 2014. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility.
Net cash provided by operating activities was $1.3 million for the nine months ended September 30, 2014 and $30.4 million for the nine months ended September 30, 2013. The $29.1 million decrease was primarily due to the payment of Brazilian income taxes under the amnesty program in August of 2014 and an increase in working capital.
Net cash used in investing activities was $33.5 million for the nine months ended September 30, 2014 and $13.3 million for the nine months ended September 30, 2013. The increase in cash used in investing activities of $20.2 million was primarily due to the increase in capital expenditures of $18.1 million and a decrease in proceeds for the sale of property and equipment of $2.1 million.
Net cash provided by financing activities was $26.7 million for the nine months ended September 30, 2014. Net cash used in financing activities was $2.9 million for the nine months ended September 30, 2013, respectively. The increase of $29.6 million was primarily the result of the increase of $28.6 million in net borrowings and a decrease in the payment of financing fees and the payment of obligations under capital leases.

32


As of September 30, 2014, the outstanding balance of our term debt under the Term Credit Facility and Notes (each defined below) was $463.0 million, which is net of a $0.9 million discount. In addition, as of September 30, 2014, an aggregate of $37.1 million is available for additional borrowings under the ABL Facility. This availability represents a borrowing base of $47.5 million under the ABL Facility less $10.4 million of that facility committed for letters of credit or additional borrowings. Additionally, at September 30, 2014, the Company had approximately $4.7 million available for borrowings under other small lines of credit.
We expect to incur expenses of approximately $2.0 million to $4.0 million related to the continuation of our restructuring initiatives for the remainder of 2014. We have incurred $15.7 million in the nine months ended September 30, 2014. Actual restructuring costs for 2014 may substantially differ from estimates at this time, depending on the timing of the restructuring activities and the required actions to complete them.

Capital Expenditures
For the nine months ended September 30, 2014 and 2013, we had capital expenditures of $33.7 million . We are currently targeting capital expenditures for 2014 to be approximately $53.0 million. We analyze our planned capital expenditures, based on investment opportunities available to us and our financial and operating performance, and accordingly, actual capital expenditures may be more or less than this amount. We intend to use existing cash and cash from operations to fund our capital expenditures.
See “Credit Facility and Notes” below for a description on limitations on capital expenditures imposed by our Credit Facility.

Credit Facility and Notes

On May 17, 2013, we entered into a Credit and Guaranty Agreement for a $200.0 million term loan credit facility (the “Term Credit Facility”), net of a discount of $1.0 million, among us, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions. We also entered into a Revolving Credit and Guaranty Agreement originally for a $40.0 million asset-based revolving credit facility subject to a borrowing base among us, Xerium Canada Inc., as Canadian borrower, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions (the "Domestic Revolver"). On March 3, 2014, we entered into an amendment to the Revolving Credit and Guaranty Agreement (as amended, the “ABL Facility,” and collectively with the Term Credit Facility, the “Credit Facility”) to add the Company's German subsidiaries as European Borrowers (the "European Borrowers") and to provide for an additional $15 million European asset-based revolving credit facility subject to a European borrowing base (the "European Revolver"), increasing the aggregate availability under the ABL Facility to $55 million.
The Term Credit Facility provides for:
a six-year $200 million senior secured term loan facility, provided the facility would mature in March 2018 if any of our 8.875% senior unsecured notes due 2018 in the aggregate principal amount of $240 million (the “Notes”) remain outstanding at that time;
an accordion option (the “Incremental Facility”) allowing for increases for borrowings under the Term Credit Facility with the same terms, and borrowing of new tranches of term loans, up to an aggregate principal amount equal to (i) $75 million plus (ii) an additional amount (the “Facility Increase”) provided, if after giving effect to such Facility Increase (as well as any other additional term loans), on a pro forma basis, the Senior Secured Leverage Ratio (as defined in the Term Credit Facility) for the most recent four consecutive fiscal quarters does not exceed 2.25:1; and
in connection with the amendment to the ABL Facility, the Term Credit Facility was amended to permit the ABL Facility to be further increased by an additional $10 million, to a total aggregate availability of not more than $65 million, provided that if the ABL Facility is increased beyond $55 million, certain baskets for additional indebtedness and liens otherwise available to us under the Term Loan Facility will be reduced dollar-for-dollar by any additional increase to the ABL Facility.
On August 18, 2014, we entered into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”). Under the Second Amendment, we borrowed an additional $30 million by utilizing the Incremental Facility. The $30 million in additional borrowings was used to finance a tax amnesty payment in Brazil. See Note 4, Income Taxes, for a discussion of our participation in a tax amnesty program in Brazil. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility.
The Domestic Revolver provides for a $40 million senior secured revolving credit facility with a $20 million sub-limit on letters of credit. The European Revolver provides for a $15 million senior secured revolving credit facility with a $10

33


million sub-limit on letters of credit. Availability under both the Domestic Revolver and the European Revolver is subject to a borrowing base that is based on a specified percentage of eligible accounts receivable and inventory. The term of the ABL Facility is five years, provided that if any of the Notes remain outstanding in March 2018, the ABL Facility would mature at that time.
The interest rates under the Term Credit Facility are calculated, at our option, at either the base rate or LIBOR, plus a margin of 4.00% and 5.00%, respectively. Each of the base rate and LIBOR is subject to a minimum of 2.25% and 1.25%, respectively. If our Senior Secured Leverage Ratio (as defined in the Credit Facility) is less than 2.00:1 at any quarterly determination date, then the margins over the base rate and LIBOR will be 3.50% and 4.50%, respectively.
Depending on whether advances are made in U.S. Dollars or Canadian Dollars, interest rates under the Domestic Revolver are calculated, at our option, at either a U.S.-based or Canadian-based base rate ("Base Rate Loans") or LIBOR or the Canadian Dealer Offered Rate ("CDOR") (each, "Fixed Rate Loans"), respectively, plus a margin of 0.75% for Base Rate Loans and a margin of 1.75% for Fixed Rate Loans. If we draw advances on the Domestic Revolver that are equal to or greater than 33.3% but less 66.7% of the $40 million limit, then the margins on Base Rate Loans and Fixed Rate Loans increase to 1.00% and 2.00%, respectively. The margins rise to 1.25% and 2.25%, respectively, if advances under the Domestic Revolver are equal to or greater than 66.7% of the $40 million limit. Interest rates under the European Revolver are calculated, at either LIBOR or Overnight LIBOR, plus a margin of 1.75%. If the European Borrowers draw advances on the European Revolver that are equal to or greater than 33.3% but less than 66.7% of the $15 million limit, then the margin increases to 2.00%. The margin rises to 2.25% if advances under the European Revolver are equal to or greater than 66.7% of the $15 million limit. In addition to paying interest on outstanding advances under the ABL Facility, we are required to pay a commitment fee to the lenders in respect of the unutilized commitments at a rate equal to 0.50% per annum if advances under the ABL Facility are less than or equal to 50% of the commitments or a rate equal to 0.375% per annum if advances under the ABL are more than 50% of the commitments.
The obligations under the Credit Facility are guaranteed by all of our existing and future direct and indirect subsidiaries that are organized in the United States, and, in the case of the European Revolver, by each other European borrower, certain other of the Company's European subsidiaries and any existing or future direct or indirect subsidiaries that become a party to the ABL Facility.
The Credit Facility contains certain customary covenants that, subject to exceptions, restrict our ability to, among other things:
declare dividends or redeem or repurchase equity interests;
prepay, redeem or purchase debt;
incur liens and engage in sale-leaseback transactions;
make loans and investments;
incur additional indebtedness;
amend or otherwise alter debt and other material agreements;
make capital expenditures in excess of $42 million per fiscal year, subject to adjustment;
engage in mergers, acquisitions and asset sales;
transact with affiliates; and
engage in businesses that are not related to the Company's existing business.
The Credit Facility eliminates the interest coverage and leverage coverage ratio maintenance tests that were contained in our 2011 Credit Facility. However, the ABL Facility contains a springing Fixed Charge Coverage Ratio (as defined in the ABL Facility), which must be not less than 1.00:1 during periods in which our Global Excess Availability (as defined in the ABL Facility) falls below certain minimum thresholds.
On May 26, 2011, we completed a refinancing transaction, which replaced certain of its then outstanding indebtedness with the senior unsecured notes payable semi-annually, bearing interest at 8.875% per annum (the "Notes"). The Notes contain customary covenants that, subject to certain exceptions, restrict its ability to enter into certain transactions and engage in certain activities. The Company has $236.4 million aggregate principal amount outstanding as of September 30, 2014 under the Notes.
We are in compliance with all covenants under the Notes and Credit Facility at September 30, 2014.
Critical Accounting Policies
The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses. Actual results could differ from those estimates.

34


Our significant policies are described in the notes to the condensed consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2013. Judgments and estimates of uncertainties are required in applying our accounting policies in many areas. There have been no material changes to the critical accounting policies affecting the application of those accounting policies as noted in our Annual Report on Form 10-K for the year ended December 31, 2013.
Non-GAAP Financial Measures
We use EBITDA and Adjusted EBITDA (each as defined in the Credit Facility) as supplementary non-GAAP liquidity measures to assist us in evaluating our liquidity and financial performance, specifically our ability to service indebtedness and to fund ongoing capital expenditures. Neither EBITDA nor Adjusted EBITDA should be considered in isolation or as a substitute for income from operations or cash flows (as determined in accordance with GAAP).
EBITDA is defined as net income before interest expense, income tax provision and depreciation (including non-cash impairment charges) and amortization.
“Adjusted EBITDA” means, with respect to any period, the total of (A) the consolidated net income for such period, plus (B) without duplication, to the extent that any of the following were deducted in computing such consolidated net income for such period: (i) provision for taxes based on income or profits, including, without limitation, federal, state, provincial, franchise and similar taxes, including any penalties and interest relating to any tax examinations, (ii) consolidated interest expense, (iii) consolidated depreciation and amortization expense, (iv) reserves for inventory in connection with plant closures, (v) consolidated operational restructuring costs, (vi) non-cash charges resulting from the application of purchase accounting, including push-down accounting, (vii) non-cash expenses resulting from the granting of common stock, stock options, restricted stock or restricted stock unit awards under equity compensation programs solely with respect to common stock, and cash expenses for compensation mandatorily applied to purchase common stock, (viii) non-cash items relating to a change in or adoption of accounting policies, (ix) non-cash expenses relating to pension or benefit arrangements, (x) expenses incurred as a result of the repurchase, redemption or retention of common stock earned under equity compensation programs solely in order to make withholding tax payments, (xi) amortization or write-offs of deferred financing costs, (xii) any non-cash losses resulting from mark to market hedging obligations (to the extent the cash impact resulting from such loss has not been realized in such period) and (xiii) other non-cash losses or charges (excluding, however, any non-cash loss or charge which represents an accrual of, or a reserve for, a cash disbursement in a future period), minus (C) without duplication, to the extent any of the following were included in computing consolidated net income for such period, (i) non-cash gains with respect to the items described in clauses (vi), (vii), (ix), (xi), (xii) and (xiii) (other than, in the case of clause (xiii), any such gain to the extent that it represents a reversal of an accrual of, or reserve for, a cash disbursement in a future period) of clause (B) above and (ii) provisions for tax benefits based on income or profits. Notwithstanding the foregoing, Adjusted EBITDA, as defined in the Credit Facility and calculated below, may not be comparable to similarly titled measurements used by other companies.
Consolidated net income is defined as net income determined on a consolidated basis in accordance with GAAP; provided, however, that the following, without duplication, shall be excluded in determining consolidated net income: (i) any net after-tax extraordinary or non-recurring gains, losses or expenses (less all fees and expenses relating thereto), (ii) the cumulative effect of changes in accounting principles, (iii) any fees and expenses incurred during such period in connection with the issuance or repayment of indebtedness, any refinancing transaction or amendment or modification of any debt instrument, in each case, as permitted under the Credit Facility and (iv) any cancellation of indebtedness income.
The following table provides reconciliation from net income and operating cash flows, which are the most directly comparable GAAP financial measures, to EBITDA and Adjusted EBITDA.

35


 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2014
 
2013
 
2014
 
2013
Net (loss) income
$
(20,472
)
 
$
2,104

 
$
(18,542
)
 
$
711

Stock-based compensation
709

 
547

 
1,858

 
1,141

Depreciation
8,183

 
8,384

 
24,950

 
26,051

Amortization of intangibles
231

 
407

 
1,230

 
1,368

Deferred financing cost amortization
942

 
675

 
2,409

 
2,293

Foreign exchange loss (gain) on revaluation of debt
396

 
(1,296
)
 
(340
)
 
1,626

Deferred tax expense
2,460

 
591

 
1,509

 
1,339

Asset impairment
277

 

 
277

 
1,078

(Gain) loss on disposition of property and equipment
(33
)
 
161

 
(4
)
 
154

Loss on extinguishment of debt

 

 

 
3,123

Net change in operating assets and liabilities
(292
)
 
4,986

 
(12,030
)
 
(8,453
)
Net cash (used) provided by operating activities
(7,599
)
 
16,559

 
1,317

 
30,431

Interest expense, excluding amortization
8,650

 
8,703

 
24,576

 
29,404

Net change in operating assets and liabilities
292

 
(4,986
)
 
12,030

 
8,453

Current portion of income tax expense
26,758

 
2,472

 
31,931

 
7,716

Stock-based compensation
(709
)
 
(547
)
 
(1,858
)
 
(1,141
)
Foreign exchange (loss) gain on revaluation of debt
(396
)
 
1,296

 
340

 
(1,626
)
Asset impairment
(277
)
 

 
(277
)
 
(1,078
)
Gain (loss) on disposition of property and equipment
33

 
(161
)
 
4

 
(154
)
Loss on extinguishment of debt

 

 

 
(3,123
)
EBITDA
26,752

 
23,336

 
68,063

 
68,882

Loss on extinguishment of debt

 

 

 
3,123

Stock-based compensation
709

 
547

 
1,858

 
1,141

Operational restructuring expenses
3,466

 
3,034

 
15,712

 
8,454

Non-restructuring impairment expense

 
1

 

 
667

Inventory write off due to plant closures

 

 

 
692

Plant startup costs
537

 
296

 
953

 
296

Adjusted EBITDA
$
31,464

 
$
27,214

 
$
86,586

 
$
83,255





36



ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk
Our interest rate risks as of September 30, 2014 have not materially changed from December 31, 2013 (see Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2013). As of September 30, 2014, we had outstanding long-term debt with a carrying amount of $463.6 million with an approximate fair value of $480.3 million.
Foreign Currency Risk
As discussed in Note 6 to the Consolidated Financial Statements, both the Euro and the Brazilian Real declined significantly from December 31, 2013. These declines had an unfavorable impact of approximately $(20.0) million on our foreign subsidiaries net equity balances at September 30, 2014.

 
ITEM 4.
CONTROLS AND PROCEDURES
(a) Evaluation of Disclosure Controls and Procedures. We have carried out an evaluation, as of September 30, 2014 under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a–15(e) and 15d–15(e) under the Securities Exchange Act of 1934, as amended (the “Act”). Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms; and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. No evaluation of disclosure controls and procedures can provide absolute assurance that these controls and procedures will operate effectively under all circumstances. However, our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective at the reasonable assurance level as set forth above.
(b) Changes in Internal Control over Financial Reporting. No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Act) occurred during the quarter ended September 30, 2014 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS
There have been no material developments to the legal proceedings described in our Annual Report on Form 10-K for the year ended December 31, 2013. See Notes 4 and 9 to our Unaudited Condensed Consolidated Financial Statements for a discussion of our tax settlement with the Brazilian government and other routine litigation to which we are subject.

ITEM 1A.
RISK FACTORS
The risks described in our Annual Report on Form 10-K for the year ended December 31, 2013 have not materially changed.
ITEM 6.    EXHIBITS
See the exhibit index following the signature page to this Quarterly Report on Form 10-Q.


37




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
XERIUM TECHNOLOGIES, INC.
 
(Registrant)
 
 
 
November 3, 2014
By:              
/s/Clifford E. Pietrafitta
 
 
Clifford E. Pietrafitta
 
 
Executive Vice President and CFO
 
 
(Principal Financial Officer)


38



EXHIBIT INDEX
 
Exhibit  
Number   
 
Description of Exhibits
 
 
10.1
 
Second Amendment to Credit and Guaranty Agreement dated August 18, 2014 (filed as Exhibit 10.1 to the Registrant's Form 8-K filed on August 22, 2014, and incorporated herein by reference)
 
 
 
10.2
 
Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement dated August 14, 2014
 
 
 
31.1
 
Certification Statement of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
31.2
 
Certification Statement of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1
 
Certification Statement of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
32.2
 
Certification Statement of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101.INS
 
XBRL Instance Document
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document







39


September 9, 2014

VIA OVERNIGHT COURIER

Xerium Technologies, Inc.
Xerium Canada Inc.
14101 Capital Boulevard
Youngsville, North Carolina 27596
Attn: Teresa K. Kazaglis

Huyck, Wangner Germany GMBH
Robec Walzen GMBH
Stowe Woodward Aktiengesellschaft
Am Langen Graben 22
52353 Düren, Germany
Attn: Oliver Häkel

Re:     Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement (this "Amendment")

Ladies and Gentlemen:

XERIUM TECHNOLOGIES, INC., a Delaware corporation (the "Lead Borrower"), any Subsidiary of the Lead Borrower organized or formed under the laws of the United States that at any time becomes a US Borrower (each a "US Borrower" and, together with the Lead Borrower, the "US Borrowers"), XERIUM CANADA INC., a corporation organized under the laws of the Province of New Brunswick ("Xerium Canada"), and any other Subsidiary of the Lead Borrower organized or formed under the laws of Canada or any province or territory thereof that at any time becomes a Canadian Borrower (each a "Canadian Borrower" and, together with Xerium Canada, the "Canadian Borrowers"), HUYCK.WANGNER GERMANY GMBH, a limited liability company (Gesellschaft mit beschränkter Haftung) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Stuttgart under registration number HRB 353855 (the "European Lead Borrower"), ROBEC WALZEN GMBH, a limited liability company (Gesellschaft mit beschränkter Haftung) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Düren under registration number HRB 2867 ("Robec Germany"), STOWE WOODWARD AKTIENGESELLSCHAFT, a stock corporation (Aktiengesellschaft) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Düren under registration number HRB 2635 ("Stowe Germany"), (European Lead Borrower, Robec Germany and Stowe Germany are each a "European Borrower" and collectively, the "European Borrowers"; and the European Borrowers, together with the US Borrowers and the Canadian Borrowers, collectively, the "Borrowers"), CERTAIN SUBSIDIARIES OF THE LEAD BORROWER, as Guarantors, the Lenders party thereto from time to time, PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent (together with its permitted successors, in such capacity, "Administrative Agent") and as Collateral Agent (together with its permitted successors, in such capacity, "Collateral Agent") and JPMORGAN CHASE BANK, N.A., as European Administrative Agent (together with its permitted successors, in such capacity, "European Administrative Agent") and as European Collateral Agent (together with its permitted successors, in such capacity, "European Collateral Agent"), are parties to that certain First Amended and Restated Revolving Credit and Guaranty Agreement dated March 3, 2014 (as at any time amended, modified, restated, or supplemented, the "Credit Agreement"; all capitalized terms used herein but not otherwise defined shall have



the meanings given such terms in the Credit Agreement), pursuant to which the Lenders party thereto, the Administrative Agent and the European Administrative Agent have made certain advances and financial accommodations available to Borrowers. The parties desire to amend the Credit Agreement as hereinafter set forth including to, among other things, ensure that any cash and treasury management products and services provided by a Lender Counterparty to any Credit Party or any Subsidiary of a Credit Party are Obligations and Guaranteed Obligations under the Credit Agreement and are secured by the Collateral.

NOW, THEREFORE, for and in consideration of Ten Dollars ($10.00) in hand paid and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

The Credit Agreement is hereby amended by:

(a) deleting the definition of "Canadian Cash Management Products and Services" in Section 1.1 of the Credit Agreement and by substituting the following in lieu thereof:

Canadian Cash Management Products and Services” means agreements or other arrangements entered into with a Lender Counterparty in the Lead Borrower’s or any of its Subsidiaries’ Ordinary Course that provides any of the following products or services to the Lead Borrower or any of its Subsidiaries: (a) credit cards; (b) credit card processing services; (c) debit cards and stored value cards; (d) purchase cards; (e) ACH transactions; (f) cash management and treasury management services and products, including controlled disbursement accounts or services, lockboxes, automated clearinghouse transactions, overdrafts, interstate depository network services; or (g) foreign currency exchange and foreign currency swaps and hedges. The indebtedness, obligations and liabilities of the Lead Borrower and all of its Subsidiaries to the provider of any of the foregoing products or services (including all obligations and liabilities owing to such provider in respect of any returned items deposited with such provider) (the “Canadian Cash Management Obligations”) shall be “Obligations” hereunder, “Canadian Obligations” hereunder, Guaranteed Canadian Obligations under the Guaranty and secured obligations under the Canadian Collateral Documents, as applicable, and otherwise treated as Canadian Obligations for purposes of each of the other Credit Documents.
(b) deleting, from clause (b) of the definition of "Eligible Receivables" in Section 1.1 of the Credit Agreement, the phrase "(or, in the case of an Eligible Receivable of a European Borrower, ninety (90) days)";
(c) deleting the definition of "European Cash Management Products and Services" in Section 1.1 of the Credit Agreement and by substituting the following in lieu thereof:

European Cash Management Products and Services” means agreements or other arrangements entered into with a Lender Counterparty in the Lead Borrower’s or any of its Subsidiaries’ Ordinary Course that provides any of the following products or services to the Lead Borrower or any of its Subsidiaries: (a) credit cards; (b) credit card processing services; (c) debit cards and stored value cards; (d) purchase cards; (e) ACH transactions; (f) cash management and treasury management services and products, including controlled disbursement accounts or services, lockboxes, automated clearinghouse transactions, overdrafts, interstate depository network services; or (g) foreign currency exchange and foreign currency swaps and hedges. The indebtedness, obligations and liabilities of the Lead Borrower and all of its Subsidiaries to the provider of any of the foregoing products or



services (including all obligations and liabilities owing to such provider in respect of any returned items deposited with such provider) (the “European Cash Management Obligations”) shall be “Obligations” hereunder, “European Obligations” hereunder, Guaranteed European Obligations under the Guaranty and secured obligations under the European Collateral Documents, as applicable, and otherwise treated as European Obligations for purposes of each of the other Credit Documents.

(d) deleting the definition of "US Cash Management Products and Services" in Section 1.1 of the Credit Agreement and by substituting the following in lieu thereof:

US Cash Management Products and Services” means agreements or other arrangements entered into with a Lender Counterparty in the Lead Borrower’s or any of its Subsidiaries’ Ordinary Course that provides any of the following products or services to the Lead Borrower or any of its Subsidiaries: (a) credit cards; (b) credit card processing services; (c) debit cards and stored value cards; (d) purchase cards; (e) ACH transactions; (f) cash management and treasury management services and products, including controlled disbursement accounts or services, lockboxes, automated clearinghouse transactions, overdrafts, interstate depository network services; or (g) foreign currency exchange and foreign currency swaps and hedges. The indebtedness, obligations and liabilities of the Lead Borrower and all of its Subsidiaries to the provider of any of the foregoing products or services (including all obligations and liabilities owing to such provider in respect of any returned items deposited with such provider) (the “US Cash Management Obligations”) shall be “Obligations” hereunder, "US Obligations" hereunder, Guaranteed Obligations under the Guaranty and secured obligations under the US Collateral Documents, as applicable, and otherwise treated as Obligations for purposes of each of the other Credit Documents.

(e) deleting clause (ii) of Section 2.11(b) of the Credit Agreement and substituting the following in lieu thereof:

(ii) have an expiry date not later than twelve (12) months after such Letter of Credit’s date of issuance (or, in the case of European Letters of Credit, such longer period as the European Administrative Agent may agree) and in no event later than five (5) Business Days prior to the Revolving Commitment Termination Date.

(f) deleting the phrase "(and with respect to Sterling amounts on the actual number of days elapsed over a 365-day year)" set forth in Section 2.25 of the Credit Agreement; and

(g) deleting Exhibit B (Compliance Certificate) to the Credit Agreement and substituting Exhibit B (Compliance Certificate) attached to this Amendment in lieu thereof.

Each Credit Party, by its execution hereof, hereby ratifies and reaffirms each of the Credit Documents and all of their respective covenants, duties, indebtedness and liabilities thereunder and hereby further reaffirms each such Credit Party's guaranty of the Guaranteed Canadian Obligations, Guaranteed Obligations and Guaranteed European Obligations as further set forth in the Credit Agreement (as amended hereby).

Each Borrower hereby: (i) represents and warrants that no Event of Default exists under the Credit Agreement or any other Credit Document; (ii) acknowledges and stipulates that the Credit Agreement and the other Credit Documents are legal, valid and binding obligations of such Borrower that are enforceable against such Borrower in accordance with the terms thereof; (iii) represents and warrants that the execution,



delivery and performance of this Amendment have been duly authorized by all requisite company or corporate action on the part of such Borrower and this Amendment has been duly executed and delivered by such Borrower; and (iv) all of the Obligations are owing and payable without defense, offset or counterclaim (and to the extent there exists any such defense, offset or counterclaim on the date hereof, the same is hereby waived by such Borrower).

Upon the effectiveness of this Amendment, each reference in the Credit Agreement to "this Agreement," "hereunder," or words of like import shall mean and be a reference to the Credit Agreement, as amended by this Amendment. This Amendment shall be governed by and construed in accordance with the internal laws of the State of New York.

Except as otherwise expressly provided in this Amendment, nothing herein shall be deemed to amend or modify any provision of the Credit Agreement or any other Credit Document, all of which shall remain in full force and effect. This Amendment is not intended to be, nor shall it be construed to create, a novation or accord and satisfaction, and the Credit Agreement as herein modified shall continue in full force and effect.

[Signatures begin on following page]




This Amendment may be executed in any number of counterparts and by different parties to this Amendment on separate counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or other electronic transmission shall be deemed to be an original signature hereto. To the fullest extent permitted by applicable law, the parties hereto each hereby waives the right to trial by jury in any action, suit, counterclaim or proceeding arising out of or related to this Amendment.

Very truly yours,

JPMORGAN CHASE BANK, N.A. LONDON BRANCH as European Administrative Agent, European Collateral Agent and as a Lender

By:    /s/ Helen Mathie
Name: Helen Mathie
Title: Assistant Vice President

JPMORGAN CHASE BANK, N.A. TORONTO BRANCH, as a Lender to the extent provided in the Credit Agreement

By:    /s/ Auggie Marchem
Name: Auggie Marchem
Title: Authorized Officer
JPMORGAN CHASE BANK, N.A., as a Lender to the extent provided in the Credit Agreement

By:    /s/ Kennedy A. Capin
Name: Kennedy A. Capin
Title: Vice President
PNC BANK, NATIONAL ASSOCIATION
as Administrative Agent, Collateral Agent and as a Lender

By:    /s/ Patrick McConnell
Name: Patrick McConnell
Title: Senior Vice President
PNC BANK CANADA BRANCH
as a Lender to the extent provided in the Credit Agreement

By:    /s/ Patrick McConnell
Name: Patrick McConnell
Title: Senior Vice President





Acknowledged and Agreed:

XERIUM TECHNOLOGIES, INC.
By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: VP, Treasurer
HUYCK LICENSCO INC.


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
ROBEC BRAZIL LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
STOWE WOODWARD LICENSCO LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
STOWE WOODWARD LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
WANGNER ITELPA I LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
WANGNER ITELPA II LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer

Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement




WEAVEXX, LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
XERIUM ASIA, LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
XERIUM III (US) LIMITED


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
XERIUM IV (US) LIMITED


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
XERIUM V (US) LIMITED


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
XTI LLC


By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer

Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement




XERIUM CANADA INC.
By: /s/ Teresa K. Kazaglis
Name: Teresa K. Kazaglis
Title: Treasurer
HUYCK.WANGNER GERMANY GMBH
By: /s/ Michael S. Buchanan
Name: Michael S. Buchanan
Title: Managing Director
ROBEC WALZEN GMBH
By: /s/ Michael S. Buchanan
Name: Michael S. Buchanan
Title: Managing Director
STOWE WOODWARD
AKTIENGESELLSCHAFT



By: /s/ Dave Pretty
Name: Dave Pretty
Title: Managing Director
XERIUM GERMANY HOLDING GMBH
By: /s/ Michael S. Buchanan
Name: Michael S. Buchanan
Title: Managing Director
XERIUM TECHNOLOGIES LTD
By: /s/ Michael S. Buchanan
Name: Michael S. Buchanan
Title: Director


Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement




Exhibit B
Form of Compliance Certificate

(attached)


Second Amendment to First Amended and Restated Revolving Credit and Guaranty Agreement



EXHIBIT B TO
FIRST AMENDED AND RESTATED REVOLVING CREDIT AND GUARANTY AGREEMENT
[FORM OF COMPLIANCE CERTIFICATE]
COMPLIANCE CERTIFICATE THE
UNDERSIGNED HEREBY CERTIFIES AS FOLLOWS:
1.
I am the [Chief Financial Officer][Treasurer] of XERIUM TECHNOLOGIES, INC. (“Xerium” or the “Lead Borrower”) .
2.
I have reviewed the terms of that certain FIRST AMENDED AND RESTATED REVOLVING CREDIT AND GUARANTY AGREEMENT dated as of March 3, 2014 (as it may be further amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; terms defined therein and not otherwise defined herein are being used herein as therein defined) by and among the Lead Borrower, any Subsidiary of the Lead Borrower organized or formed under the laws of the United States that at any time after the date hereof becomes a US Borrower in accordance with the terms thereof (each a “US Borrower” and, together with the Lead Borrower, the “US Borrowers”), Xerium Canada, Inc., a corporation organized under the laws of the Province of New Brunswick (“Xerium Canada”), and any other Subsidiary of the Lead Borrower organized or formed under the laws of Canada or any province or territory thereof that at any time after the date hereof becomes a Canadian Borrower in accordance with the terms thereof (each a “Canadian Borrower” and, together with Xerium Canada, the “Canadian Borrowers”), Huyck.Wangner Germany GmbH, a limited liability company (Gesellschaft mit beschränkter Haftung) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Stuttgart under registration number HRB 353855 (the “European Lead Borrower”), Robec Walzen GmbH, a limited liability company (Gesellschaft mit beschränkter Haftung) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Düren under registration number HRB 2867 (“Robec Germany”), Stowe Woodward Aktiengesellschaft, a stock corporation (Aktiengesellschaft) organized under the laws of Germany and registered with the commercial register (Handelsregister) of the local court (Amtsgericht) Düren under registration number HRB 2635 (“Stowe Germany”), (European Lead Borrower, Robec Germany and Stowe Germany are each a “European Borrower” and collectively, the “European Borrowers”; and the European Borrowers, together with the US Borrowers and the Canadian Borrowers, collectively, the “Borrowers”), certain Subsidiaries of the Lead Borrower, as Guarantors, the Lenders party thereto from time to time, PNC Bank, National Association, as Administrative Agent (together with its permitted successors, in such capacity, “Administrative Agent”) and as Collateral Agent (together with its permitted successors, in such capacity, “Collateral Agent”) and JPMorgan Chase Bank, N.A., as European Administrative Agent (together with its permitted successors, in such capacity, “European Administrative Agent”; the Administrative Agent and European Administrative Agent are collectively, the “Agents”)





and as European Collateral Agent (together with its permitted successors, in such capacity, “European Collateral Agent”).
[Use following paragraph 3 for monthly financial statements]
3.
As required by Section 5.1(a) of the Credit Agreement, attached hereto as Annex A are the consolidated and consolidating balance sheets of the Lead Borrower and its Subsidiaries as at the end of the month ended on [mm/dd/yr] (and a separate balance sheet covering the European Borrowers on a stand-alone basis) and the related consolidated and consolidating statements of income, stockholders’ equity and cash flows of the Lead Borrower and its Subsidiaries (and separate such statements covering the European Borrowers on a stand-alone basis) for such month and for the period from the beginning of the then current Fiscal Year to the end of such month, setting forth, in each case, in comparative form the corresponding figures for the corresponding periods of the previous Fiscal Year. As at such date and for such period, such financial statements were prepared in conformity with GAAP and to my knowledge fairly present, in all material respects, the financial position, on a consolidated or consolidating, as applicable, basis, of the Lead Borrower and its Subsidiaries as at the respective dates thereof and the results of operations and cash flows, on a consolidated or consolidating, as applicable, basis, of the Lead Borrower and its Subsidiaries for each of the periods then ended, subject to changes resulting from audit and normal year-end adjustments. The consolidating financial statements are in the form that Xerium currently files with the Securities and Exchange Commission as part of its Form 10-Q, except for the inclusion of statements provided with respect to the European Borrowers on a stand-alone basis.
The aggregate amount of Consolidated Capital Expenditures made pursuant to Section 6.8 of the Credit Agreement (exclusive of Capital Expenditures paid with Net Asset Sale Proceeds or with Net Insurance/Condemnation proceeds) for the period from January 1, [20__] through the end of the month ended on [mm/dd/yr] was $[_____], of which (i) $[_____] represented use of the Roll-Over Amount (if any) from the preceding Fiscal Year, (ii) $[_____] represented use of the Maximum Consolidated Capital Expenditures for the immediately succeeding Fiscal Year, (iii) $[_____] represented use of the $10,000,000 permitted by Section 6.8 of the Credit Agreement for replacement of the non-equipment operating leases in effect on the Closing Date with respect to the facilities located in Youngsville, North Carolina and Geelong, Australia with Capital Leases and (iv) $[_____] represented Consolidated Capital Expenditures made in reliance on the Applicable Conditions.
[Use following paragraph 3 for quarterly financial statements]
3.
As required by Section 5.1(a) of the Credit Agreement, attached hereto as Annex A are the consolidated and consolidating balance sheets of the Lead Borrower and its Subsidiaries as at the end of the Fiscal Quarter ended on [mm/dd/yr] (and a separate balance sheet covering the European Borrowers on a stand-alone basis) and the related consolidated and consolidating statements of income, stockholders’ equity and cash flows of the Lead Borrower and its Subsidiaries (and separate such statements covering the European





Borrowers on a stand-alone basis) for such Fiscal Quarter and for the period from the beginning of the then current Fiscal Year to the end of such Fiscal Quarter, setting forth, in each case, in comparative form the corresponding figures for the corresponding periods of the previous Fiscal Year. As at such date and for such period, such financial statements were prepared in conformity with GAAP and to my knowledge fairly present, in all material respects, the financial position, on a consolidated or consolidating, as applicable, basis, of the Lead Borrower and its Subsidiaries as at the respective dates thereof and the results of operations and cash flows, on a consolidated or consolidating, as applicable, basis, of the Lead Borrower and its Subsidiaries for each of the periods then ended, subject to changes resulting from audit and normal year-end adjustments. The consolidating financial statements are in the form that Xerium currently files with the Securities and Exchange Commission as part of its Form 10-Q, except for the inclusion of statements provided with respect to the European Borrowers on a stand-alone basis.
The aggregate amount of Consolidated Capital Expenditures made pursuant to Section 6.8 of the Credit Agreement (exclusive of Capital Expenditures paid with Net Asset Sale Proceeds or with Net Insurance/Condemnation proceeds) for the period from January 1, [20__] through the end of the Fiscal Quarter ended on [mm/dd/yr] was $[_____], of which (i) $[_____] represented use of the Roll-Over Amount (if any) from the preceding Fiscal Year, (ii) $[_____] represented use of the Maximum Consolidated Capital Expenditures for the immediately succeeding Fiscal Year, (iii) $[_____] represented use of the $10,000,000 permitted by Section 6.8 of the Credit Agreement for replacement of the non-equipment operating leases in effect on the Closing Date with respect to the facilities located in Youngsville, North Carolina and Geelong, Australia with Capital Leases and (iv) $[_____] represented Consolidated Capital Expenditures made in reliance on the Applicable Conditions.
[Use following paragraph 3 for fiscal year-end financial statements]
3.
As required by Section 5.1(b) of the Credit Agreement, attached hereto as Annex A are the audited consolidated and unaudited consolidating balance sheets of the Lead Borrower and its Subsidiaries as at the end of the Fiscal Year ended on [mm/dd/yr] (and a separate balance sheet covering the European Borrowers on a stand-alone basis) and the related consolidated and consolidating statements of income, stockholders’ equity and cash flows of the Lead Borrower and its Subsidiaries (and separate such statements covering the European Borrowers on a stand-alone basis) for such Fiscal Year, setting forth, in each case, in comparative form the corresponding figures for the previous Fiscal Year, together with, in the case of the audited consolidated financial statements, a report thereon of Ernst & Young LLP or other independent certified public accountants of recognized international standing selected by the Lead Borrower, which report is unqualified as to going concern and scope of audit, and states that such consolidated financial statements fairly present, in all material respects, the consolidated financial position of the Lead Borrower and its Subsidiaries as at the dates indicated and the results of their operations and their cash flows for the periods indicated in conformity with GAAP applied on a basis consistent with prior years (except as otherwise disclosed in such financial statements). The consolidating financial statements





(i) fairly represent, in all material respects, the consolidating financial position of the Lead Borrower and its Subsidiaries as at the respective dates thereon and the consolidating results of operations and cash flows of the Lead Borrower and its Subsidiaries for each of the periods then ended, and (ii) are in the form that Xerium currently files with the Securities and Exchange Commission as part of its Form 10-K, except for the inclusion of statements provided with respect to the European Borrowers on a stand-alone basis.
The aggregate amount of Consolidated Capital Expenditures made pursuant to Section 6.8 of the Credit Agreement (exclusive of Capital Expenditures paid with Net Asset Sale Proceeds or with Net Insurance/Condemnation Proceeds) for the period from January 1, [20__] through the end of the Fiscal Year ended on [mm/dd/yr] was $[_____], of which (i) $[_____] represented use of the Roll-Over Amount (if any) from the preceding Fiscal Year, (ii) $[_____] represented use of the Maximum Consolidated Capital Expenditures for the immediately succeeding Fiscal Year, (iii) $[_____] represented use of the $10,000,000 permitted by Section 6.8 of the Credit Agreement for replacement of the non-equipment operating leases in effect on the Closing Date with respect to facilities located in Youngsville, North Carolina and Geelong, Australia with Capital Leases and (iv) $[_____] represented Consolidated Capital Expenditures made in reliance on the Applicable Conditions.
4.
As of the date hereof, a Covenent Trigger Period [does/does not] exist.
[Include the following language if a Covenant Trigger Period exists and monthly financial statements are being delivered:] The Fixed Charge Coverage Ratio as of the most recently ended Fiscal Quarter (for the period of four (4) consecutive Fiscal Quarters then ended) is [___].
[Include the following language if a Covenant Trigger Period exists and quarterly or fiscal year-end financial statements are being delivered:] As required by Section 6.17 of the Credit Agreement, the Fixed Charge Coverage Ratio in respect of the last period of four (4) consecutive Fiscal Quarters is [__], which [is/is not] in compliance with the required Fixed Charge Coverage Ratio of 1.00:1.00. Set forth on Annex B hereto are the computations in reasonable detail showing such amount.
5.
The examination described in paragraph 2 above did not disclose, and I have no knowledge of, the existence of any condition or event which constitutes a Default or an Event of Default during or at the end of the accounting period covered by the attached financial statements or as of the date of this Certificate, except as set forth in a separate attachment, if any, to this Certificate, describing in detail, the nature of the condition or event, the period during which it has existed and the action which the Lead Borrower has taken, is taking, or proposes to take with respect to each such condition or event.
6.
The foregoing certifications, together with the financial statements delivered with this Certificate and in support hereof, are made and delivered [mm/dd/yr] pursuant to Section 5.1(c) of the Credit Agreement.






[Use following paragraph 7 for Applicable Conditions compliance in connection with a proposed Permitted Acquisition]

7.
As required by clause (vii) of the definition of “Permitted Acquisition” in the Credit Agreement, attached hereto as Annex C are computations showing (in reasonable detail) that the Applicable Conditions have been satisfied on a pro forma basis after giving effect to such acquisition as of the last day of the Fiscal Quarter most recently ended (as determined pursuant to Section 1.4 of the Credit Agreement).

XERIUM TECHNOLOGIES, INC., as Lead Borrower

By:_____________________________

Name:

Title:






ANNEX A TO
COMPLIANCE CERTIFICATE
FINANCIAL STATEMENTS
FOR THE [MONTH] [FISCAL QUARTER] [FISCAL YEAR] ENDED [mm/dd/yr].
[See attached]





ANNEX B TO
COMPLIANCE CERTIFICATE
FOR THE [FISCAL QUARTER] [FISCAL YEAR] ENDED [mm/dd/yr].

1. Adjusted EBITDA: (i) + (ii) -(iii):
$[___, __, ___]
(i) the total of the Consolidated Net Income of the Lead Borrower and its Subsidiaries for such period:
$[___, __, ___]
(ii) without duplication, to the extent that any of the following were deducted in computing item (i) above, the total of:
$[___, __, ___]
(a) provision for taxes based on income or profits, including without limitation, federal, state, provincial, franchise and similar taxes, including any penalties and interest relating to any tax examinations:
$[___, __, ___]
(b) Consolidated Interest Expense:
$[___, __, ___]
(c) Consolidated Depreciation and Amortization Expense, including depreciation and amortization expenses related to Capital Leases:
$[___, __, ___]
(d) reserves for inventory in connection with plant closures:
$[___, __, ___]
(e) Consolidated Operational Restructuring Costs:
$[___, __, ___]
(f) non-cash charges resulting from the application of purchase accounting including push-down accounting:
$[___, __, ___]
(g) non-cash expenses resulting from the granting of Common Stock, stock options, restricted stock or restricted stock unit awards under equity compensation programs solely with respect to Common Stock, and cash expenses for compensation mandatorily applied to purchase Common Stock:
$[___, __, ___]
(h) non-cash items relating to a change in or adoption of accounting policies:
$[___, __, ___]
(i) non-cash expenses relating to pension or benefit arrangements:
$[___, __, ___]
(j) expenses incurred as a result of the repurchase, redemption or retention by the Lead Borrower of Common Stock earned under equity compensation programs solely in order to make withholding tax payments:
$[___, __, ___]
(k) amortization or write-offs of deferred financing costs:
$[___, __, ___]
(l) any non-cash losses resulting from marking to market Hedging Obligations (to the extent the cash impact resulting from such loss has not been realized in such period):
$[___, __, ___]





(m) other non-cash losses or charges (excluding, however, any non-cash loss or charge which represents an accrual of, or a reserve for, a cash disbursement in a future period)
$[___, __, ___]
(iii) without duplication, to the extent any of the following were included in computing item (i) above for such period:
$[___, __, ___]
(a) non-cash gains with respect to the items described in clauses (f), (g), (i), (k), (l) and (m) of clause (ii) above:
$[___, __, ___]
(b) provisions for tax benefits based on income or profits:
$[___, __, ___]
 
 
2. Consolidated Net Income: (i) – (ii):
$[___, __, ___]
(i) the net income (loss) of the Lead Borrower and its Subsidiaries for such period determined on a consolidated basis in accordance with GAAP:
$[___, __, ___]
(ii) the sum, without duplication, of the following:
$[___, __, ___]
(A) any net after-tax extraordinary or non-recurring gains, losses or expenses (less all fees and expenses relating thereto):
$[___, __, ___]
(B) the cumulative effect of changes in accounting principles:
$[___, __, ___]
(C) any fees and expenses incurred in connection with the issuance or repayment of Indebtedness, any refinancing transaction or amendment or modification of any debt instrument permitted under the Credit Agreement:


$[___, __, ___]
(D) any cancellation of indebtedness income:
$[___, __, ___]
 
 
3. Fixed Charge Coverage Ratio: ((i)-(ii))/(iii):
[__]: 1:00
(i) Adjusted EBITDA:
$[___, __, ___]

(ii) the sum of the following:
 
(A) all cash Capital Expenditures made during such period (except to the extent financed with (x) Indebtedness for borrowed money other than with the Advances or other working capital revolving credit facilities, (y) Net Asset Sale Proceeds or (z) Net Insurance/Condemnation Proceeds):
$[___, __, ___]

(B) all taxes paid in cash during such period:
$[___, __, ___]
(C) all cash dividends or other cash distributions made on account of the Lead Borrower’s Capital Stock and all cash repurchases or redemptions of the Lead Borrower’s Capital Stock, in each case, made during such period:


$[___, __, ___]





(iii) all Fixed Charges paid or payable in cash for such period:
$[___, __, ___]

 
 
4. Fixed Charges: (i) + (ii):
$[___, __, ___]
(i) Consolidated Interest Expense during such period
$[___, __, ___]
(ii) all regularly scheduled (as determined as of the first day of the respective period) and mandatory principal payments of Indebtedness (including the principal component of Capital Leases) made or required to be made during such period:
$[___, __, ___]
 
 






ANNEX C TO
COMPLIANCE CERTIFICATE
FOR THE [QUARTER] [YEAR] ENDED [mm/dd/yr].
1. Adjusted EBITDA: (i) + (ii) -(iii):
$[___, __, ___]
(i) the total of the Consolidated Net Income of the Lead Borrower and its Subsidiaries for such period:
$[___, __, ___]
(ii) without duplication, to the extent that any of the following were deducted in computing item (i) above, the total of:
$[___, __, ___]
(a) provision for taxes based on income or profits, including without limitation, federal, state, provincial, franchise and similar taxes, including any penalties and interest relating to any tax examinations:
$[___, __, ___]
(b) Consolidated Interest Expense:
$[___, __, ___]
(c) Consolidated Depreciation and Amortization Expense, including depreciation and amortization expenses related to Capital Leases:
$[___, __, ___]
(d) reserves for inventory in connection with plant closures:
$[___, __, ___]
(e) Consolidated Operational Restructuring Costs:
$[___, __, ___]
(f) non-cash charges resulting from the application of purchase accounting including push-down accounting:
$[___, __, ___]
(g) non-cash expenses resulting from the granting of Common Stock, stock options, restricted stock or restricted stock unit awards under equity compensation programs solely with respect to Common Stock, and cash expenses for compensation mandatorily applied to purchase Common Stock:
$[___, __, ___]
(h) non-cash items relating to a change in or adoption of accounting policies:
$[___, __, ___]
(i) non-cash expenses relating to pension or benefit arrangements:
$[___, __, ___]
(j) expenses incurred as a result of the repurchase, redemption or retention by the Lead Borrower of Common Stock earned under equity compensation programs solely in order to make withholding tax payments:
$[___, __, ___]
(k) amortization or write-offs of deferred financing costs:
$[___, __, ___]
(l) any non-cash losses resulting from marking to market Hedging Obligations (to the extent the cash impact resulting from such loss has not been realized in such period):
$[___, __, ___]





(m) other non-cash losses or charges (excluding, however, any non-cash loss or charge which represents an accrual of, or a reserve for, a cash disbursement in a future period)
$[___, __, ___]
(iii) without duplication, to the extent any of the following were included in computing item (i) above for such period:
$[___, __, ___]
(a) non-cash gains with respect to the items described in clauses (f), (g), (i), (k), (l) and (m) of clause (ii) above:
$[___, __, ___]
(b) provisions for tax benefits based on income or profits:
$[___, __, ___]
 
 
2. Consolidated Net Income: (i) – (ii):
$[___, __, ___]
(i) the net income (loss) of the Lead Borrower and its Subsidiaries for such period determined on a consolidated basis in accordance with GAAP:
$[___, __, ___]
(ii) the sum, without duplication, of the following:
$[___, __, ___]
(A) any net after-tax extraordinary or non-recurring gains, losses or expenses (less all fees and expenses relating thereto):
$[___, __, ___]
(B) the cumulative effect of changes in accounting principles:
$[___, __, ___]
(C) any fees and expenses incurred in connection with the issuance or repayment of Indebtedness, any refinancing transaction or amendment or modification of any debt instrument permitted under the Credit Agreement:


$[___, __, ___]
(D) any cancellation of indebtedness income:
$[___, __, ___]
 
 
3. Fixed Charge Coverage Ratio: ((i)-(ii))/(iii):
[__]: 1:00
(i) Adjusted EBITDA:
$[___, __, ___]

(ii) the sum of the following:
 
(A) all cash Capital Expenditures made during such period (except to the extent financed with (x) Indebtedness for borrowed money other than with the Advances or other working capital revolving credit facilities, (y) Net Asset Sale Proceeds or (z) Net Insurance/Condemnation Proceeds):
$[___, __, ___]

(B) all taxes paid in cash during such period:
$[___, __, ___]
(C) all cash dividends or other cash distributions made on account of the Lead Borrower’s Capital Stock and all cash repurchases or redemptions of the Lead Borrower’s Capital Stock, in each case, made during such period:



$[___, __, ___]





(iii) all Fixed Charges paid or payable in cash for such period:
$[___, __, ___]

 
 
4. Fixed Charges: (i) + (ii):
$[___, __, ___]
(i) Consolidated Interest Expense during such period
$[___, __, ___]
(ii) all regularly scheduled (as determined as of the first day of the respective period) and mandatory principal payments of Indebtedness (including the principal component of Capital Leases) made or required to be made during such period:
$[___, __, ___]
 
 
5. Global Excess Availability: (i) – (ii):
$[___, __, ___]
(i) the lesser of: (x) the Borrowing Base and (y) the Maximum Credit:
$[___, __, ___]
(ii) the sum of:
 
(A) the Dollar Equivalent of the aggregate principal amount of all then outstanding and unpaid Advances plus the Dollar Equivalent of the aggregate amount of all then outstanding Letter of Credit Obligations:
$[___, __, ___]
(B) the aggregate amount of all then outstanding and unpaid trade payables and other obligations of the Borrowers which are either past due beyond the due date therefor by at least sixty (60) days (other than trade payables or other obligations being contested or disputed by the Borrowers in good faith):
$[___, __, ___]
 
 
6. 90-Day Global Excess Availability: (i)/(ii):
$[___, __, ___]
(i) the sum of each day’s Global Excess Availability during the 90 consecutive day period immediately preceding such date (or, if shorter, the period commencing on the Closing Date and ending on the day immediately preceding such date):
$[___, __, ___]
(i) 90 (or, if applicable, the number of days (which is less than 90) from the Closing Date to the day immediately preceding such date):
[__]
 
 
 
 







Exhibit 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Harold C. Bevis, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Xerium Technologies, Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 3, 2014
 
 
/s/ Harold C. Bevis
Harold C. Bevis
President and Chief Executive Officer
(Principal Executive Officer)






Exhibit 31.2
CHIEF FINANCIAL OFFICER CERTIFICATION
I, Clifford E. Pietrafitta, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Xerium Technologies, Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 3, 2014
 
/s/ Clifford E. Pietrafitta
Clifford E. Pietrafitta
Executive Vice President and CFO
(Principal Financial Officer)






Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer of Xerium Technologies, Inc. (the “Company”), does hereby certify that, to his knowledge:
1) the Company’s Form 10-Q for the period ended September 30, 2014, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2) the information contained in the Company’s Form 10-Q for the period ended September 30, 2014, fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
/s/ Harold C. Bevis
Harold C. Bevis
President and Chief Executive Officer
(Principal Executive Officer)
November 3, 2014






Exhibit 32.2
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal financial officer of Xerium Technologies, Inc. (the “Company”), does hereby certify that, to his knowledge:
1) the Company’s Form 10-Q for the period ended September 30, 2014, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2) the information contained in the Company’s Form 10-Q for the period ended September 30, 2014, fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Clifford E. Pietrafitta
Clifford E. Pietrafitta
Executive Vice President and CFO
(Principal Financial Officer)
November 3, 2014


Xerium (NYSE:XRM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Xerium Charts.
Xerium (NYSE:XRM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Xerium Charts.